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Necrotizing fasciitis infections have high mortality rates especially when treatment is 
delayed. Despite the abundance of research in many areas of necrotizing fasciitis 
infection, there are limited and conflicting studies focusing on gender-related outcomes 
for those diagnosed and died with necrotizing fasciitis infection. The purpose of this 
study was to determine the association that gender plays on survival time of patients who 
have been diagnosed with necrotizing fasciitis using a cross-sectional study design. 
Succeeding the conceptual design of the life course model, the research question tested 
whether there was a significant difference in survival time between the genders while in 
the hospital. Additionally, the research questions tested whether gender-related survival 
was modified by sociodemographic factors or mediated by risk factors for survival of 
necrotizing fasciitis. Kaplan-Meir method was used to examine survival times between 
genders. The Cox Proportional Hazards model was used to examine effect modification 
and mediation. Secondary data from the State Inpatient Databases (SID) and the National 
Inpatient Sample (NIS) was obtained and used. The result illustrated that there is no 
difference in survival by gender. However, among men, survival is modified by age. 
Additionally, diabetes diagnosis tends to affect the survival time for both males and 
females. The research contributed to social change by increasing the knowledge and 
understanding of necrotizing fasciitis infections and mortality factors. The results of this 
study aid in the treatment of necrotizing fasciitis infections for health professionals and 










MPH, Walden University, 2012 
BS, Everglades University, 2009 
 
 
Dissertation Submitted in Partial Fulfillment 
of the Requirements for the Degree of 
Doctor of Philosophy 








This dedication is for my family and friends who have guided, inspired, and 
encouraged me through my life. My grandmother who is the smartest person I know. My 
mother who reached her goals of a doctoral degree at 58 but also makes time for silliness. 
My father who first taught me curiosity but also patience. My daughter, Bailey, niece, 
Leah, and cousins who renew my passion for improving the world in a small way daily. 
My brother who continually teaches me, even if I don’t care to hear it. My extended 
family and close friends who stay connected, motivate me, teach me, and help me enjoy 




My guiding light through this process who has been invaluable with insight, 
knowledge, kindness, honesty, and so much more, Dr. Chinaro Kennedy, the chair of my 
dissertation. I would not have learned or grown academically as much without you as my 
chair and for that I will be eternally grateful. You have been rigorously truthful but gentle 
enough to keep me motivated and encouraged me to do better.  
I would like to thank Dr. Mark White, my committee member, for his concise 
feedback, support, encouragement, and added knowledge. He provided wonderful ideas 
and stayed positive throughout this process and for all of that I am very thankful for him.  
Next, I would like to thank you to Dr. Simone Salandy, my URR, who gave excellent 
feedback and was prompt and thorough. I value the attention that you give and highly 
appreciate what you do.    
Last, I would like to give a continual thank you to my family and friends. Both 
have inspired me indefinitely. My friends, at Walden University, have shown me there is 
a light at the end of the tunnel and helped me stay on track and challenged me to staying 
motivated. My friends outside of my academic life have shown me that each of us have 
our own special story and journey and have helped me stay connected to the world. My 
family who put up with crazy hours and perhaps a slightly crazy person for quite some 
time during this process. Your support and love have driven me to make the world a 




Table of Contents 
Introduction ....................................................................................................................1 
Background ....................................................................................................................3 
Diagnosis of necrotizing fasciitis ...................................................................................4 
Treatment of necrotizing fasciitis ..................................................................................5 
Management of Infection ...............................................................................................6 
Problem Statement .........................................................................................................7 
Purpose of the Study ......................................................................................................8 
Research Questions ........................................................................................................8 
Theoretical Framework ..................................................................................................9 
Nature of the Study ......................................................................................................10 
Definitions....................................................................................................................13 
Assumptions .................................................................................................................14 
Scope and Delimitations ..............................................................................................14 
Limitations ...................................................................................................................15 
Significance and Social Change Implications ..............................................................15 
Summary ......................................................................................................................16 
Introduction ..................................................................................................................18 
Literature Search Strategy............................................................................................18 
Theoretical Framework ................................................................................................19 
Historical Perspective ..................................................................................................20 
Current Trends .............................................................................................................21 
 
ii 
Literature Review Related to Key Variables ...............................................................23 
Mortality and Survival Analysis for Necrotizing Fasciitis ..........................................23 
Gender Associated with Survival of Necrotizing Fasciitis ..........................................27 
Diabetes, Obesity, and Chronic Renal Disease Association with Survival of 
Necrotizing Fasciitis ........................................................................................29 
Age, Insurance, and Region of Residence Association with Survival of 
Necrotizing Fasciitis ........................................................................................30 
Summary and Conclusion ............................................................................................32 
Introduction ..................................................................................................................34 
Research Design and Rationale ...................................................................................35 
Justification for Using the Design................................................................................35 
Operational Use of the Conceptual Framework...........................................................36 
Methodology ................................................................................................................38 
Population ....................................................................................................................38 
Sampling and Sampling Procedure ..............................................................................39 
Data Collection ............................................................................................................40 
Use of Archival Data ...................................................................................................41 
Data Analysis Plan .......................................................................................................43 
Threats to Validity .......................................................................................................46 





Data Collection ............................................................................................................51 
Data Analysis ...............................................................................................................51 
Results 52 
Descriptive Statistics ....................................................................................................52 
Statistical Assumptions ................................................................................................54 
Research Question 1 and Hypothesis 1 ........................................................................56 
Research Question 2 and Hypothesis 2 ........................................................................57 
Research Question 3 and Hypothesis 3 ........................................................................64 
Summary ......................................................................................................................70 
Interpretation of Findings ............................................................................................73 
Limitations of the Study...............................................................................................76 







Chapter 1: Introduction to the Study  
Introduction 
One of the rarest but deadliest infectious diseases, necrotizing fasciitis, also 
known as flesh eating bacteria, has a history that dates back to Hippocratic times while 
noted as a disease that made flesh, sinews, and bones fall away (Green et al., 1996). 
Necrotizing fasciitis is now described as a bacterial infection that affects the fascia and 
subcutaneous fat that results in death of the epidermis (Shimizu & Tokuda, 2010). 
Currently, the incident rate for necrotizing fasciitis is only at 0.40 per 100,000 people in 
United States with average incidence ranging from 500 to 1,500 new cases (Shimizu & 
Tokuda, 2010). Mortality rate of necrotizing fasciitis is as high as 32% to 65% 
(Mukhopadhyay, Saha, Biswas, & Biswas, 2011, p. 7). Many reports have noted a five-
fold increase in necrotizing fasciitis in the last decade (Mukhopadhyay et al., 2011). 
Moreover, the average cost for treating necrotizing fasciitis per patient is roughly $50,000 
to $100,000 (Faucher, Morris, Edelman, & Saffle, 2001; Widjaja, Tran, Cleland, Leung, 
& Millar, 2005). Accordingly, the length of stay in a hospital ranges from 13 days to 172 
days depending on the numerous complications that can arise from necrotizing fasciitis 
infections (Mulla, Gibbs, & Aronoff, 2006).  
In a study over long-term outcomes for necrotizing fasciitis patients, Light et al. 
(2010) who collected data from 1998 to 2006 from a single university-based Burn and 
Trauma Center found that 87 of the 377 patients in the study died within 10 years of 
being hospitalized for necrotizing fasciitis infection (p. 99). Light et al. (2010) noted a 
tendency of women having a higher mortality rate than men in long-term survival (p. 99).  
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Light et al. (2010) study included patients from age 1 to 89 with a median age range of 49 
(p. 99). In a population-level study conducted by Oud and Watkins (2015) the 
investigators found, among woman hospitalized for necrotizing fasciitis, the odds of 
mortality were higher compared to similarly hospitalized men (p. 5). However, Oud and 
Watkins (2015) noted “conflicting data on the role of gender on patient outcomes in 
severe infectious” (p. 7) remain an issue. Thus, this study will provide information 
regarding the differences in gender and survival time for patients hospitalized for 
necrotizing fasciitis infections.  
Chapter 1 is divided into 12 sections. All sections in this chapter convey relevant 
information regarding the topic. The introduction and background illustrate the gap in 
literature and give contextual information over the topic. The problem statement 
illustrates the evidence and meaning to the topic. The purpose of the study offers 
information regarding the study design. The research questions outline the variables 
being studied. The theoretical framework clarifies the approach of the study. The nature 
of the study outlines the variables, methodology, data collection procedures, and what 
type of data is being used. The definitions section describes the main variables in the 
study. The assumptions section addresses the suppositions of the study. The scope and 
delimitations section defines the boundaries of the study and gives insight into validity 
and generalizability of the study. The limitations section outlines the parameters of the 
study. Finally, the significance and social change of the study gives insight into positive 




As early as the 1950s, infectious disease researchers noted connections between 
necrotizing fasciitis and other bacteria (McCloskey, 1973; Noble, 1969; Taviloglu & 
Yanar, 2007). Clinical research consistently found two main pathogenic causes of 
necrotizing fasciitis which included Staphylococcus aureus and Streptococcus bacteria 
(McCloskey, 1973; Noble, 1969). Research now separates necrotizing fasciitis into four 
types (Davoudian & Flint, 2012; Hassal, Fagan, Carson, & Currie, 2010). The first type, 
type 1, the most common type of infection, results from a polymicrobial infection with 
sources deriving from four different microbes, which are mixed anaerobe and aerobe 
organisms (Davoudian & Flint, 2012; Hassel et al., 2010). Type I necrotizing fasciitis 
infections commonly occurs on the trunk and perineal sites among immunocompromised 
and diabetic patients (Davoudian & Flint, 2012; Hassel et al., 2010). Type II necrotizing 
fasciitis is a monomicrobial infection resulting from Streptococcus pyogenes or 
Staphylococcus aureus, and is less common than type I necrotizing fasciitis (Davoudian 
& Flint, 2012; Hassel et al., 2010). Type II is linked to toxic shock and occurs frequently 
with people with addiction disorders (Davoudian & Flint, 2012; Hassel et al., 2010). 
Type III necrotizing fasciitis is uncommon but is associated with higher levels of 
mortality at 40% and is connected to Vibrio damselae, Vibrio Vulnificus, or other Vibrio 
species (Davoudian & Flint, 2012; Hassel et al., 2010). Type IV necrotizing fasciitis is 
connected to fungal infections and is very unusual (Davoudian & Flint, 2012; Hassel et 
al., 2010). Type IV necrotizing fasciitis is connected with traumatic injuries and burns 
(Davoudian & Flint, 2012; Hassel et al., 2010).  
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Diagnosis of necrotizing fasciitis 
Researchers have focused fairly extensively on examining quick diagnosis and 
treatment of necrotizing fasciitis (Taviloglu & Yanar, 2007). When symptoms occur, 
early diagnosis is one of the key elements to decreasing morbidity and increasing survival 
among those infected with necrotizing fasciitis (Bair et al., 2009; Davoudian & Flint, 
2012; Mukhopadhyay et al., 2011). Early diagnostics have proven to be complicated for 
necrotizing fasciitis. Some of the reasons for the complications include: many different 
types of bacteria causing necrotizing fasciitis infections, the location of the infected site 
or absence of portal entry, identification of symptoms, and risk factors associated with 
necrotizing fasciitis (Bair et al., 2009; Davoudian & Flint, 2012; Mukhopadhyay et al., 
2011). The ideal criterion for diagnosis whether necrotizing fasciitis is present is through 
surgical exploration and tissue biopsy (Bair et al., 2009; Davoudian & Flint, 2012; 
Mukhopadhyay et al., 2011). However, if the patient is not severely ill then laboratory 
tests should be conducted. These laboratory tests include serum chemistry studies, 
imaging of infected site, and complete blood count with differentials, arterial blood gas 
measurement, and urinalysis (Kobayashi et al., 2011).  
Moreover, color Doppler ultrasound, magnetic resonance imaging (MRI), or 
contrast-enhanced computed tomography (CT) scanning can aid in early diagnostics for 
people who necrotizing fasciitis (Kobayashi et al., 2011). If the patient is not severely ill 
and laboratory results have varying results, some studies have found that elevated white 
blood cells, increased blood urea nitrogen counts, and reduction in serum sodium levels 
are signs for necrotizing fasciitis (Bair et al., 2009; Davoudian & Flint, 2012; 
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Mukhopadhyay et al., 2011). Furthermore, needle aspiration and gram staining can be 
used to facilitate early diagnostics, as well (Bair et al., 2009; Davoudian & Flint, 2012; 
Mukhopadhyay et al., 2011). Research has indicated that needle aspiration needs to be 
taken at the edge of the tissue where the bacteria is plentiful. Gram staining can be more 
complicated due to the range of bacteria that can cause necrotizing fasciitis. However, 
gram staining can be highly effective if it is a polymicrobial infection which is frequently 
the case in necrotizing fasciitis infections (Bair et al., 2009; Davoudian & Flint, 2012; 
Mukhopadhyay et al., 2011). Lastly, there is a Laboratory Risk Indicator in Necrotizing 
Fasciitis (LRINEC) score. This diagnostic tool has capability of detecting necrotizing 
fasciitis early though sensitivity, specificity, and positive and negative predictive value 
have shown small effects in early diagnostic techniques (Holland, 2009).   
Treatment of necrotizing fasciitis 
When diagnosis is confirmed, treatment should start immediately to increase rates 
of survival and decrease the damage done from the fleshing eating bacteria (Kobayashi et 
al., 2011). Evidence suggests that antibiotic treatment and surgical debridement are the 
key elements in increasing survival for the patients who have necrotizing fasciitis (Bucca 
et al., 2012; Davoudian & Flint, 2012; Taviloglu & Yanar, 2007). Surgical debridement is 
also necessary to minimize tissue loss and possibly prevent amputation of the infected 
areas (Bucca et al., 2012; Davoudian & Flint, 2012; Taviloglu & Yanar, 2007).  There is 
controversy and conflicting evidence regarding how much tissue should be removed from 
the infected area for proper recovery and minimize loss of tissue thickness (Anaya & 
Dellinger, 2007; Meyers, 2012; Shimizu & Tokuda, 2010). In addition, antibiotics should 
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be started immediately using a broad-base antibiotic initially and a more specific targeted 
antibiotic after surgery to enhance rates of survival (Anaya & Dellinger, 2007; Meyers, 
2012; Shimizu & Tokuda, 2010). Depending on the situation and accessibility, hyperbaric 
oxygen treatment could also be considered (Anaya & Dellinger, 2007; Meyers, 2012; 
Shimizu & Tokuda, 2010). Research has suggested that hyperbaric oxygen treatment 
could decrease mortality of necrotizing fasciitis patients after surgical debridement and 
antibiotics have been completed (Anaya & Dellinger, 2007; Meyers, 2012; Shimizu & 
Tokuda, 2010). Yet, many studies have varied on the need and effectiveness of 
hyperbaric oxygen treatment (Anaya & Dellinger, 2007; Meyers, 2012; Shimizu & 
Tokuda, 2010).  
Management of Infection 
Initial management of necrotizing fasciitis depends on specific course of action, 
which typically is: (1) organ support; (2) source limitation, and: (3) precise antimicrobial 
dosage (Anaya & Dellinger, 2007; Davoudian & Flint, 2012). Due to the rising rates of 
other infections, antimicrobial dosage is recommended for patient survival rates and 
dosage should be adjusted after proper culturing of wound (Anaya & Dellinger, 2007; 
Davoudian & Flint, 2012). Regardless of what which system—circulatory, respiratory, or 
other, organ support is a necessity until systems improvements are seen (Anaya & 
Dellinger, 2007; Davoudian & Flint, 2012). Daily wound care is needed, and this 
includes: (1) cleaning; (2) tropical ointment application, and; (3) dressing for the wound 
(Anaya & Dellinger, 2007; Davoudian & Flint, 2012). Research also recommends 
vacuum closure of the wounds to decrease infections (Anaya & Dellinger, 2007; 
7 
 
Davoudian & Flint, 2012). Often, skin replacement surgery is recommended for these 
patients, which can be performed typically a few weeks after the patient recovers from 
the initial incident (Anaya & Dellinger, 2007; Davoudian & Flint, 2012).  
There are limited studies on hospital aftercare, or helping patients manage care 
while in the hospital after the initial management of necrotizing fasciitis. There are even 
fewer studies on survival factors during a hospital stay for patients with necrotizing 
fasciitis (Huang et al., 2011; Light et al., 2010). One researcher suggested teaching 
patients how to reduce a recurrence of this disease through patient education and by 
teaching patients about various components associated with this infection (Meyers, 
2012). Factors associated with survival would aid in patient education, treatment, and 
management of necrotizing fasciitis.  Moreover, patient education could include areas 
that have inadequate information, such as gender-related survival and factors associated 
with gender-related mortality for necrotizing fasciitis patients (Light et al., 2010; Oud & 
Watkins, 2015).      
Problem Statement 
Research suggests that gender difference in mortality due to necrotizing fasciitis 
infection is not well understood (Light et al., 2010; Oud & Watkins, 2015). To address 
this gap, this study aimed to examine whether there is a difference in survival times 
between men and women diagnosed with necrotizing fasciitis. Additionally, I examined 
whether there are differences in preexisting medical conditions between men and women 
that may have contributed to survival. 
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Purpose of the Study 
I used a cross-sectional study to examine the association that gender plays on 
survival time of patients who have been diagnosed with and died from necrotizing 
fasciitis. The dependent variable is survival time. The independent variable is gender. 
The covariates for mediation include diabetes, obesity, and chronic renal disease.  
Covariates for effect modification include age, insurance type, and region of residence. 
Some of the confounding factors in this study include—race and/or ethnicity, education, 
type of necrotizing fasciitis, and inter-hospital transfer while initially admitted.   
Research Questions 
Research Question 1: For the people who have been diagnosed with and died 
from necrotizing fasciitis, is there a significant difference in mean survival time between 
the genders while in the hospital? 
Ho1: There will be no significant difference in mean survival time between 
genders among those who have been diagnosed with and died from necrotizing 
fasciitis while in the hospital. 
HA1: There will be a significant difference in mean survival time between 
genders among those who have been diagnosed with and died from necrotizing 
fasciitis while in the hospital. 
Research Question 2: For the people who have been diagnosed with and died 
from necrotizing fasciitis, is any difference in mean survival time between genders while 




Ho1: The difference in mean survival time between genders while in the hospital 
is not modified by sociodemographic risk factors of age, insurance state, and 
region. 
HA2: The difference in mean survival time between genders while in the hospital 
is modified by sociodemographic risk factors of age, insurance state, and region. 
Research Question 3: For the people who have been diagnosed with and died 
from necrotizing fasciitis, is there any difference in mean survival time between genders 
while in the hospital mediated by pre-existing medical conditions of diabetes, obesity, 
and chronic renal disease?  
Ho1: The difference in mean survival time between genders while in the hospital 
is not mediated by pre-existing conditions of diabetes, obesity, and chronic renal 
disease. 
HA2: The difference in mean survival time between genders while in the hospital 
is mediated by pre-existing conditions of diabetes, obesity, and chronic renal 
disease.  
Theoretical Framework 
The conceptual framework this study used is the life course epidemiology 
approach. The origins of the life course approach root back to studies in history, 
psychology, sociology, public health, among other disciples (Ben-Shlomo & Kuh, 2002). 
The main beliefs of the life course approach are the analysis of individual and population 
lives through a multifaceted look into the organizational, cultural, and societal settings 
(Ben-Shlomo & Kuh, 2002). In the public health context, the life course approach has 
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had a major influence on chronic health conditions with an emphasis on the 
comprehension of an inter-relationship of direct and indirect exposure variables, in 
addition to genetic and psychosocial conduits (Ben-Shlomo & Kuh, 2002).  
More recently, the life course approach has appeared in infectious disease studies 
(Hall, Yee, & Thomas, 2002; Halfon, Larson, Lu, Tullis, & Russ, 2014). The stages of 
the life course approach in infectious disease research are: (1) susceptibility; (2) 
infection; (3) disease; and (4) natural history, along with phases of generativity, 
acquisition of capacity, maintenance of function, and managing decline (Hall et al., 2002; 
Halfon et al., 2014). This collaboration of new concepts in the life course approach will 
aid in the understanding of the multidimensional nature of necrotizing fasciitis infection 
through the variations of influence on infectious disease (Hall et al., 2002; Halfon et al., 
2014).  
Nature of the Study 
The cross-sectional study design was used in this inquiry. Cross-sectional design 
offers a snap shot of the variables of interest in a study (Schmidt & Kohlmann, 2008). 
There are a number of advantages in conducting a cross-sectional study. First, a cross-
sectional study is advantageous for exploratory studies (Schmidt & Kohlmann, 2008). 
Second, cross-sectional studies are less costly and do not require follow-up which 
decreases collection time for large population studies (University of Michigan, 2010). 
Lastly, cross-sectional studies are beneficial for aiding in public health planning and 
interventions for target populations (Schmidt & Kohlmann, 2008). Even though there are 
noted strengths in the use of a cross-sectional study design, there are still limitations. 
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Some disadvantages in the use of a cross-sectional study include difficulty making causal 
inference, Neyman bias, and situation or outcomes of interest may change over time 
(Schmidt & Kohlmann, 2008). For clarity, Neyman bias, which is also known as 
incidence-prevalence bias, is regarded as bias that occurs in a study when a group of 
survivors are selected that are related to prognosis factors (Delgado-Rodriguez & Llorca, 
2004).  
Cross-sectional study was chosen over experimental and quasi-experiment study 
designs for several reasons. Though experimental studies are the golden standard with 
high internal validity, there is not a need to manipulate variables in this study to analyze 
long-term outcomes in necrotizing fasciitis (Frankfort-Nachmias and Nachmias, 2008). 
Additionally, quasi-experimental designs are similar to experimental designs without 
randomization with lower cost and higher external validity but was not appropriate for 
this study due to the nature and overall objective the study seeks to accomplish which is 
assessing the survival time for patients who live through the first initial 30 days of a 
necrotizing fasciitis infection (Frankfort-Nachmias and Nachmias, 2008).  
This study examined secondary data from the State Inpatient Databases (SID) and 
the National Inpatient Sample (NIS). The SID is a family of databases which contains 
inpatient discharge abstracts of 97% of the United States community hospital discharges 
(Agency for Healthcare Research and Quality, 2015). The SID contain more than 100 
clinical and nonclinical variables; examples of the data elements contained in SID 
include: primary and secondary diagnoses and procedures, admission and discharge 
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status, patient demographic characteristics, expected payment source, total charges, and 
length of stay (Agency for Healthcare Research and Quality, 2015).  
The participants were defined by those who had been diagnosed with necrotizing 
fasciitis and died during their hospital stay for the years of 2008 through 2012. Due to the 
rarity of the disease, and to efficiently capture all possible cases of necrotizing fasciitis, I 
combined five years of data starting from 2008 from the National Inpatient Sample (NIS) 
to the SID (Charnot-Katsikas et al., 2009; Kobayaski et al. 2011; Zackarias et al., 2010). 
Additionally, participants included patients who have one of the following comorbidity 
conditions and/or risk factors: diabetic, obesity, and chronic renal disease.  
All risk factors that were obtained through hospital discharge records were under 
the other diagnoses category of the data set (Centers for Disease Control and Prevention, 
2011). All risk factors use the International Classification of Disease (ICD) 9 and/or 10. 
Diabetes were analyzed through the ICD-9 code of 250.00 to 250.93 on the hospital 
discharge data (ICD9DATA, 2014). Obesity will use ICD-9 code of 278 to 278.03. 
Lastly, the use of chronic renal failure will use ICD-10 code of 673-675 and 682-685 
(ICD9DATA, 2014). Any missing data, incomplete data, unknown values, and duplicate 
record for any variable were excluded and removed.  
The Kaplan-Meier survival curve was used to examine survival times between 
genders. The Cox Proportional Hazards model was used to examine effect modification 
and mediation. The Kaplan-Meier method can be employed to investigate differences in 
survival between men and women over time (Greenwood & Nikulin, 1996).  The Cox 
Proportional Hazards model was used as the regression model to examine time to failure 
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of an event while examining whether failure was modified or mediated by a third order 
variable.  IBM Statistical Packaging for Social Science (SPSS) 20 version will be used to 
analyze all the data. 
Definitions 
Survival time: the duration of time between one or more events happening, such as death.  
Gender: the state of being female or male. 
Necrotizing fasciitis: a bacterial infection of the fascia, the tissue that lines and separate 
muscle, and the surrounding organs.  
Diabetes: a metabolic disease in which the body’s inability to produce any or enough 
insulin causes elevated levels of glucose in the blood. 
Obesity: weight that is higher than what is considered as a healthy weight for a given 
height is described as overweight or obese. 
Chronic Renal Disease: more commonly classified as chronic kidney disease and is listed 
as stages based on the patient's level of glomerular filtration rate (GFR) which is a 
measure of filtering capacity of the kidneys. 
Age: the length of time that a person has lived. 
Insurance state: this is classified in the data as Medicaid, Medicare, private insurance, 
self-payed, no charge, or other.  
Region of Residency: The United States Census Bureau defines four regions. Region 1: 
Northeast, which will include: New England, Connecticut, Maine, Massachusetts, New 
Hampshire, Rhode Island, Vermont, New Jersey, New York, and Pennsylvania. Region 
2: Midwest, which will include: Illinois, Indiana, Michigan, Ohio, Wisconsin, Iowa, 
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Kansas, Minnesota, Missouri, Nebraska, North Dakota, and South Dakota. Region 3: 
South, which will include: Delaware, Florida, Georgia, Maryland, North Carolina, South 
Carolina, Virginia, Washington D.C., West Virginia, Alabama, Kentucky, Mississippi, 
Tennessee, Arkansas, Louisiana, Oklahoma, and Texas. Region 4: West, which will 
include: Arizona, Colorado, Idaho, Montana, Nevada, New Mexico, Utah, Wyoming, 
Alaska, California, Hawaii, Oregon, and Washington. Puerto Rico and other US 
territories are not part of any census region or census division.  
Assumptions 
This study used secondary data from State Inpatient Databases (SID) from the 
Agency for Healthcare Research and Quality (AHRQ). SID contains universal inpatient 
discharge records from 97% of U.S. community hospital discharges. The SID contains 
core set of clinical and nonclinical information on all patients. This study made the 
following assumptions with the use of the secondary data from SID: (1) the data obtained 
are accurate; (2) the data obtained are precise; and (3) the data obtained have minimal 
measurement error.  
Scope and Delimitations 
This study used a cross-sectional design using secondary archived data. The study 
covered five years of hospital discharge data starting in 2008 to 2012. The secondary data 
was analyzed and coded accordingly. All patients have died during their hospital duration 
and no personal identifiers will be used. The target population was all patients diagnosed 
with necrotizing fasciitis in the United States and died during their hospital stay. The data 
included gender, races/ethnicity, age, primary and secondary diagnosis, expected 
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payment source, and length of stay (Agency for Healthcare Research and Quality, 2015). 
Generalization will be limited to US population who would have been captured by the 
NIS database.  
Limitations 
There are several limitations in this study. The overarching limitation of this 
cross-sectional study is misclassification.  Misclassification may result from loss of 
record or improper classification. It is possible that a person’s death from necrotizing 
fasciitis may not have been captured and may have been attributed to another cause. 
While difficulty in establishing directionality and temporality is a major limitation of the 
cross-sectional design, it may not be an issue in this study, since death is final outcome, 
and by default does not have to follow any previous outcome.  
Significance and Social Change Implications 
In 2012, the media highly publicized three cases of necrotizing fasciitis in 
Georgia (Castillo, 2012). Despite information and research on necrotizing fasciitis, there 
are very few studies that have examined risk factors for surviving necrotizing fasciitis 
(Huang et al., 2011; Light et al, 2010). Light et al. (2010) found 87 of the 377 or 25% had 
a 3-year morality rate while Khamnaum et al. (2015) found 290 of the 1504 or 19.3% of 
the patients died while in the hospital. Studies show that the underlying cause of death 
among those diagnosed with necrotizing fasciitis, 3 years after initial diagnosis, was 
pneumonia, sepsis, urinary tract infections, and choleystitis (Light et al., 2010). The 
average survival time for men and women after leaving the hospital was 10 years while 
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the average age of patients was 49 years old (Light et al., 2010). However, mortality 
tended to be higher among women.   
There is the potential for several elements of positive social change in this 
dissertation. At a community level, this study can add to the knowledge of necrotizing 
fasciitis survival factors and give health practitioners and patients of necrotizing fasciitis 
a more comprehensive awareness of the infection. By using a cross-sectional study 
design, the researcher hopes to add to the body of literature on how necrotizing fasciitis 
differentially affects mortality among men and women. This study is unique in the 
manner that it is one of the initial endeavors in the United States to statistically measure 
necrotizing fasciitis in regard to gender, sociodemographic factors, and risk factors that 
can be associated with the survival time (Huang et al., 2011; Light et al., 2010). The third 
contribution is to clarify the differences in mortality for patients of necrotizing fasciitis in 
a study focused in the United States (Light et al., 2010; Oud & Watkins, 2015).   
Summary 
Necrotizing fasciitis is a rare but deadly bacterial infection. There is a high 
mortality among patients diagnosed with necrotizing fasciitis. Early diagnostics and 
quick treatment are key factors associated with surviving necrotizing fasciitis infection. 
Researchers have focused broadly in case-reports and literature and medical reviews to 
help in faster diagnostics, etiology of necrotizing fasciitis, common features through 
incidence of characteristics of necrotizing fasciitis, and treatment of necrotizing fasciitis 
but there is still conflict or lack of agreement among studies over gender-related survival 
analysis in necrotizing fasciitis patients. The next chapter will illustrate the seminal 
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articles related to necrotizing fasciitis while focusing on the study variables and the gap 







Chapter 2: Literature Review 
Introduction 
In this chapter, I illustrate the search strategies involved in the literature review. 
This review covers the theoretical foundation/conceptual framework as it is associated 
with infectious disease. I review a historical perspective of necrotizing fasciitis research. 
In this chapter, I also review the current research in necrotizing fasciitis while illustrating 
the gap in literature. Finally, I connect the variables of the study to research. The 
variables include; (1) gender with survival time analysis; (2) demographic features 
correlated to necrotizing fasciitis; (3) risk factors and survival time in necrotizing 
fasciitis.   
Literature Search Strategy 
This literature review included the evaluation of the following databases: the 
Academic Premier database of Walden University, Science Direct, Google Scholar, 
PUBMED, and MEDLINE. This approach generated hundreds of peer-reviewed articles 
over necrotizing fasciitis. Search terms consist of: necrotizing fasciitis, necrotizing 
fasciitis AND etiology, necrotizing fasciitis AND diagnosis, necrotizing fasciitis AND 
clinical features, necrotizing fasciitis AND risk factors, necrotizing fasciitis AND 
treatment, necrotizing fasciitis AND prognosis, necrotizing fasciitis AND long-term 
outcomes, outcome measures AND necrotizing fasciitis, survival analysis AND 
necrotizing fasciitis, and gender AND necrotizing fasciitis. Peer-reviewed journals were 
included that were published in English, focusing on data primarily to the variables in the 
study which include—gender with survival time analysis, demographic features 
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correlated to necrotizing fasciitis, and risk factors and survival time in necrotizing 
fasciitis. Additionally, studies will be included of necrotizing fasciitis that give more 
understanding, accuracy, and historical background. Despite the abundance of research in 
some areas of necrotizing fasciitis, many facets of research are limited.  
Theoretical Framework 
This study uses the life course approach for the theoretical framework. Initially, 
the life course approach in epidemiology was used for chronic health issues (Ben-Shlomo 
& Kuh, 2002; Hall, Yee, & Thomas, 2002). The life course approach has more recently 
been connected with infectious disease epidemiology (Halfon, Larson, Lu, Tullis, & 
Russ, 2014; Hall et al., 2002; World Health Organization, 2000). The life course 
approach in infectious disease focuses on four main influences, which are—
susceptibility, infection, disease, and natural history (Figure 1; Hall et al., 2002). 
 
Figure 1. Simplified model of influences that may affect infectious disease. From 
“Life course epidemiology and infectious diseases,” by A. Hall, L. Yee, & S. Thomas, 
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2002, International Journal of Epidemiology, 31, p. 300. Reprinted with permission (See 
Appendix A).  
 
 
Often with regard to the life course model, researchers downplay the framework 
as a common sense approach. However, the framework has enormous implications for 
understanding the different stages of health in relation to specific disease process (World 
Health Organization, 2000). This collaboration of new concepts in the life course 
approach will aid in the understanding of the multidimensional nature of necrotizing 
fasciitis infection through the variations of influence on infectious disease (Halfon et al., 
2014; Hall et al., 2002).  
Historical Perspective 
In 1871, a Confederate surgeon in the Army described necrotizing fasciitis as 
hospital gangrene with a mortality rate of 46% among 2,642 infected soldiers (Wilson, 
1952, p.417). Research around necrotizing fasciitis has been sporadic and often the main 
research tool was through case-studies (Mukhopadhyay et al., 2011). As early as 1924, 
researchers started focusing on case reports of necrotizing fasciitis and the connection to 
other bacteria associated with the infection (Meleney, 1924).  Meleney (1924) reported 
necrotizing fasciitis and its links to streptococcal infections (p.324). Fifty years later, 
necrotizing fasciitis was connected to staphylococcus aurous (Leppard & Seal, 1982; 
McCloskey, 1973).  In the initial case reports for diagnosis of necrotizing fasciitis, 
researchers looked into bacteriology and serology. The researcher’s main focus in early 
necrotizing fasciitis research was narrowing down the types of bacteria that contributed to 
the infection (Leppard & Seal, 1983). In 1995, research started to examine additional risk 
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factors for necrotizing fasciitis (Leibowitz & Ramakrishnan, 1995). There was evidence 
suggesting that age, local tissue factors, and immune status may be contributing factors to 
acquiring necrotizing fasciitis (Leibowitz & Ramakrishnan, 1995).  
Current Trends 
The bulk of necrotizing fasciitis research has focused in risk factors, diagnostics, 
treatment, and microbiology of necrotizing fasciitis since the mid-90s. Moreover, 
classification for people who are diagnosed with necrotizing fasciitis are getting more and 
more well-defined with the collective studies looking into these areas (Das, Baker, & 
Venugopal, 2012; Puvanendran, Huey, & Pasupathy, 2009). Another area of research that 
has started becoming refined is research over the risk factors for necrotizing fasciitis 
infection. Recent researchers are noting that the most common risk factor is diabetes; 
with ranges as high as 70% to 32% of patients having diabetes who are diagnosed with 
necrotizing fasciitis (Das et al., 2012, p. 2; Puvanendran et al., 2009, p. 982). Other risk 
factors for people who are diagnosed with necrotizing fasciitis include: obesity, patients 
taking immunosuppressive drugs, intravenous drug misuse/addiction problems, ages 
greater than 45 years old; chronic diseases, peripheral vascular disease, hypertension, and 
malnutrition (Das et al., 2012, p. 2; Puvanendran et al., 2009, p. 982). Necrotizing 
fasciitis occurs more often in males than females with rates ranging from 54% to 80% 
(Das et al., 2012, p. 2; Puvanendran et al., 2009, p. 982). Surgery and soft tissue 
infections are the most common precipitating events that have been linked to necrotizing 
fasciitis (Das et al., 2012; Puvanendran et al., 2009). These risk factors can aid in the 
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earlier diagnostics of necrotizing fasciitis, as well as the treatment prescribed for 
necrotizing fasciitis.  
As stated previously, treatment that has proven beneficial is early diagnostics, 
surgical debridement, and broad-spectrum antibiotics that cover the commonly suspected 
organism that caused necrotizing fasciitis (Douglas, 1996; Puvanendran et al., 2009; 
Shimzu & Tokuda, 2010). The type of antibiotics used in necrotizing fasciitis treatment 
range from clindamycin to penicillin and combinations of other antibiotics (Douglas, 
1996; Puvanendran et al., 2009; Shimzu & Tokuda, 2010). Surgical debridement is a 
necessity for survival of people who have been diagnosed with NF (Douglas, 1996; 
Puvanendran et al., 2009; Shimzu & Tokuda, 2010). Without surgical intervention than 
mortality rates rise to almost 100% of the patients with necrotizing fasciitis and still after 
surgical debridement mortality rates are at 36% for the patients with necrotizing fasciitis 
(Douglas, 1996; Puvanendran et al., 2009, p. 983; Shimzu & Tokuda, 2010, p. 1051). 
Additionally, the patients that present with the predisposing factors, especially diabetic 
patients have higher rates of mortality than the people outside of the predisposing factors 
for necrotizing fasciitis (Douglas, 1996; Puvanendran et al., 2009; Shimzu & Tokuda, 
2010).  
The microbiology of necrotizing fasciitis is refined with the growing body of 
case-studies that researchers include in their analysis of necrotizing fasciitis. Initially, 
researchers described necrotizing fasciitis through multiple terminologies, including: 
necrotizing erysipelas, acute infective gangrene, hemolytic Streptococcus, dermal 
gangrene, and supportive fasciitis (Douglas, 1996; Erstad et al., 1992). Currently, the 
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microbiology of necrotizing fasciitis is has a more straightforward description (Anaya & 
Dellinger, 2007; Hunter et al., 2011). Consequently, necrotizing fasciitis research in early 
diagnostics, risk factors, treatment, and the microbiology of necrotizing fasciitis have 
been well-established through a multitude of case-studies, retrospective reviews, and 
clinical evaluations over the infections (Das et al., 2012; Puvanendran et al., 2009). These 
studies help add to the literature of necrotizing fasciitis research, assist in understanding 
more about the bacterial infection, and aid in how practitioners respond to the infection.  
Literature Review Related to Key Variables 
When I started my review of the literature, I observed that there is a significant 
and concerning gap in the literature regarding survival analysis and gender of patients 
with necrotizing fasciitis in the United States. Only a small amount of quantitative studies 
found in the literature indicate attention to the study variables, survival analysis, and 
patients with necrotizing fasciitis. Even fewer studies have been conducted in the United 
States over the survival analysis, the study variables, and patients with necrotizing 
fasciitis. In order to support positive social change and increase knowledge of necrotizing 
fasciitis infections and the variables that contribute to survival and non-survival during 
hospital stay, this study was initiated. This next section will illustrate the seminal articles 
over the variables in this study and the gap in literature.   
Mortality and Survival Analysis for Necrotizing Fasciitis 
Recently, researchers have started focusing on predictors of mortality in 
necrotizing fasciitis patients. It has been helpful to examine the variables associated with 
survival and non-survival of patients with necrotizing fasciitis because it aids in quicker 
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diagnosis, shapes better treatment, and illuminates areas that need to be managed through 
long-term care options. In one of the first studies to look at mortality rate, the researchers 
examined the histopathologic stage of necrotizing fasciitis of 82 cases from January 1990 
to December 2002 from the Mayo clinic (Bakleh et al., 2005). In this retrospective study, 
there were only 25 patients out of the 82 with a histopathologic classification scheme 
(Bakleh et al., 2005). The researchers found that patients with stage I findings had 
statistically significantly lower mortality than patients with stage III findings, with an 
odds ratio of 0.1; 95% CI, 0.001-0.8 (Bakleh et al., 2005, p. 413). Limitations in the study 
were the sample size and study design (Bahleh et al., 2005).  
After Bakleh et al. (2005), more researchers started looking into outcomes and 
probability of mortality (Golger, Ching, Goldsmith, Pennie, & Bain, 2007; Yaghoubian, 
de Virgilio, Dauphine, Lewis, & Lin, 2007). Golger et al. (2007) retrospectively reviewed 
necrotizing fasciitis patients from hospitals in Ontario, Canada from 1994 to 2001. The 
researchers analyzed demographic, comorbid illness, and disease-specific data with the 
association of mortality (Golger et al., 2007). The researchers found that age with an odds 
ratio of 1.04, 95 percent confidence interval, 1.01 to 1.08; p = 0.012, immune status with 
an odds ratio of 3.97, 95 percent confidence interval, 1.04 to 15.19; p = 0.044, and 
streptococcal toxic shock syndrome with an odds ratio of 10.54, 95 percent confidence 
interval, 2.80 to 39.44; p < 0.001, were independent predictors of mortality in patients 
with necrotizing fasciitis (Golger et al., 2007). Limitations in Golger et al. study is the 
retrospective study design (p. 1807). Yaghoubian et al. (2007) examined simple 
admission laboratory values in Los Angeles Biomedical Institute from 1997 to 2006 to 
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try to predict mortality in patients with necrotizing fasciitis. The variables that were used 
in their study included: age, race, medical history, physical examination findings, 
radiographic findings, cause of infection, primary site infection, vital signs, levels of 
serum sodium, potassium, chloride, bicarbonate, urea nitrogen, creatinine, glucose, lactic 
acid, albumin (base excess or base deficit), white blood cell count, and anion gap to 
analyze and classify patients into high and low risk groups for mortality (Yaghoubian et 
al., 2007). The researchers found that history of cancer, intravenous drug abuse, being 
transferred outside the hospital, admissions temperature, low systolic blood pressure on 
admissions, base deficit, and elevated white blood cell count were factors associated with 
mortality in patients with necrotizing fasciitis (Yaghoubian et al., 2007). Additionally, the 
researchers found that admission serum lactate greater than 54.1mg/dL had a mortality 
rate of 32% and patients with serum lactate level less than 54.1 mg/dL combined with a 
serum sodium level less than 135 mEq/L had a mortality of 19% during their time in the 
hospital (Yaghoubian et al., 2007, p. 3). Limitations in Yaghoubian et al. (2007) study 
were the retrospective design and limited studies using the CART analysis tool (p.846).  
Su et al. (2008) used a retrospective cohort study in two hospitals in Taiwan 
during 2002 to 2005. The researchers used the Laboratory Risk Indicator for Necrotizing 
Fasciitis (LRINEC score) to predict outcomes of patients who had necrotizing fasciitis 
(Su et al., 2008). The LRINEC included the following variables: C - reactive protein, 
total white cell count, hemoglobin, sodium, creatinine, and glucose to score a patient on a 
scale of 0 to 13 (Su et al., 2008). A score of less than or equal to 6 on the LRINEC test 
and amputation was associated with higher mortality (Su et al., 2008, p. 970). Su et al. 
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(2008) was the first to look into the LRINEC score and mortality. Limitations in this 
study include—LRINEC scores for diagnosis should be used cautiously, missing 
information through hospital discharge records, influence of therapies in patients, and use 
of retrospective study design (Su et al., 2008).  
Following Su et al. (2008), two other researchers found further innovative 
approaches to assess mortality in necrotizing fasciitis patients (Lee et al., 2011; Fann, 
Chiang, Hsiao, Hong, & Chen, 2011). Lee et al. (2011) retrospectively examined 46 
patients with monomicrobial necrotizing fasciitis from Chang Gung Memorial Hospital. 
The researchers classified patients into either gram-positive cocci or gram-negative 
bacillus (Lee et al., 2011). The group that was gram-positive for cocci had a higher 
prevalence of gouty arthritis whereas the group put into gram-negative bacillus had 
higher incidence of hemorrhagic bullae, septic shock, thrombocytopenia, and chronic 
liver dysfunction (Lee et al., 2011). The non-survivors of necrotizing fasciitis were 
patients with chronic liver dysfunction, chronic renal failure, reduced serum albumin 
values, thrombocytopenia, and immature leukocyte more than 10% (Lee et al., 2011, p. 
4). Though, Lee et al. (2011) found no statistical difference in LRINEC score, age, 
gender infection location, or isolated pathogenic bacterium between survivors and non-
survivors (Lee et al., 2011). Limitations in Lee et al. were small sample size, use of 
consecutive serious of patients for cohort, and the grouping of patients in cohort study (p. 
7).  
Similar to Yaghoubian et al. (2007), Fann et al. (2011) used a retrospective review 
of two hospitals in Taiwan from 2002 to 2005. The researchers identified clinical 
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admission characteristics and laboratory findings to differentiate between high and low 
morality risk groups in patients with necrotizing fasciitis (Fann et al., 2011). 
Additionally, parallel to Yaghoubain et al. (2007) the researchers used a C4.5 decision 
tree to analyze 23 clinical characteristics and laboratory tests to examine outcome 
measures (Fann et al., 2011). Differing from Yaghoubain et al. (2007), these researchers 
found three independent predictors of mortality for patients with necrotizing fasciitis, 
which are: increase in immature neutrophils, hypotension, and left shift in the differential 
white blood cell count (Fann et al., 2011). Weaknesses in the Fann et al. study were study 
design and prior antibiotic treatment in patients (p. 107).  
Gender Associated with Survival of Necrotizing Fasciitis 
Researchers have examined the incidence of male-to-female ratio of who acquires 
necrotizing fasciitis (Ryseel et al., 2010; Shukry & Ommen, 2013; Vijayakumar, 
Pullagura, & Thimmappa, 2014). However, there have been relatively limited studies that 
have looked into gender as one of the factors for survival or non-survival after diagnosed 
with necrotizing fasciitis. Light et al. (2010) found that there was a trend toward higher 
mortality among woman than men in long-term survival after diagnosed with necrotizing 
fasciitis (p. 99). Though, Light et al. (2010) did not concentrate on gender as a variable in 
their study.  
Khamnuan et al. (2015) retrospectively reviewed three hospitals in Thailand 
during 2009 to 2012. Khamnuan et al. (2015) looked for clinical predictors of mortality 
of patients with necrotizing fasciitis (p.1). There were 1,504 patients included in the study 
(Khamnuan et al., 2015). The researchers found being female with a risk ratio of 1.37 
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was one of the factors associated with mortality (Khamnuan et al., 2015). Among the 
other findings, chronic heart disease with risk ratio of 1.64, cirrhosis with a risk ratio of 
2.36, age greater than 60 with a risk ratio of 1.39, skin necrosis with a risk ratio of 1.22, 
pulse greater than 130/min with a risk ratio of 2.26, systolic blood pressure less than 90 
mmHg with a risk ratio of 2.05, and serum creatinine of greater than or equal to 1.6 
mg/dL with a risk ratio of 3.06 were associated with mortality among necrotizing fasciitis 
patients (Khamnuan et al., 2015). Limitations in Khamnuan et al. study were omission of 
LRINEC and APACHE II scoring systems to patients, retrospective study design, 
insufficient medical records (p.6). Wang and Lim (2013) retrospectively reviewed 
hospital records from 2004 to 2011 at Mackay Memorial Hospital in Taitung. Wang and 
Lim (2013) found a risk factors associated with death were gender, hospital days, and 
albumin level (p. 139). Wang and Lim (2013) found men having a lower risk of death 
than females with an odds ratio of 0.18 (p. 139). Weaknesses in Wang and Lim study 
were the retrospective study design and small sample size (p.143).  
Consequently, and as previously mentioned, Lee et al. (2011) found no statistical 
difference in gender between survivors and non-survivors (Lee et al., 2011). Because 
there are conflicting results from Khamnuan et al. (2015), Wang and Lim (2013), and Lee 
et al. (2011) studies and none of the studies have been conducted in the United States, 
there is a need to further investigate how gender is associated with survivor and non-
survivors of people diagnosed with necrotizing fasciitis in the United States.  
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Diabetes, Obesity, and Chronic Renal Disease Association with Survival of 
Necrotizing Fasciitis  
  Diabetes and being obese have been identified as leading risk factors associated 
with acquiring necrotizing fasciitis (Lee et al., 2011; Oud & Watkins, 2015; Wang & 
Lim, 2013).  Chronic renal disease has varied between studies for being a predominant 
risk factor for necrotizing fasciitis infection but often stays at the forefront of 
characteristics of necrotizing fasciitis patients (Lee et al., 2011; Oud & Watkins, 2015; 
Wang & Lim, 2013).  In a cohort study from 2001 to 2010 using Texas Inpatient Public 
Use Data File, the researchers performed a one of the largest population-based 
examination of patterns of necrotizing fasciitis (Oud & Watkins, 2015). There were 
12,172 patients included in the study who were hospitalized for necrotizing fasciitis (Oud 
& Watkins, 2015). Oud and Watkins (2015) discovered that 47.6% of the patients who 
were diagnosed with necrotizing fasciitis had diabetes, 15.2% of the patients with 
necrotizing fasciitis were obese, and 15.5% of patients with necrotizing fasciitis had 
chronic renal failure (p.3). Oud and Watkins found that diabetes had an odds ratio of 0.75 
and a p-value of 0.0023 of predicting mortality among patients with necrotizing fasciitis 
(p. 5). Oud and Watkins (2015) also found that obesity had an odds ratio of 0.532 and a 
p-value of <0.0001 of predicting mortality among patients with necrotizing fasciitis 
patients (p.5). Additionally, Oud and Watkins (2015) found that chronic renal disease had 
an odds ratio of 1.738 with a p-value of <0.0001 for predicting mortality with patients of 
necrotizing fasciitis (p. 5). Oud and Watkins (2015) did not statistically evaluate if 
survival and non-survival of necrotizing fasciitis patients with diabetes, obesity, and/or 
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chronic renal disease was mediated by gender. Though, Oud and Watkins (2015) did note 
that the “findings of reduced risk of death among males with necrotizing fasciitis contrast 
the lack of gender-related prognostic impact reported by others” (p. 7). Weakness in Oud 
and Watkins study include use of administrative data excluded timeliness of diagnosis, 
details, source control, resuscitative interventions in institutional outcomes, and 
generalizability was only to Texas population (p.8).  
Parallel to the Oud and Watkins study, Lee et al. (2011) found mortality to be 
higher among patients with chronic renal failure with a p-value of 0.015 (p.4). Lee et al. 
(2011) did not find a statistical difference in diabetes between survivors and non-
survivors of necrotizing fasciitis (p.139). Obesity was not statistically evaluated in this 
study (Lee et al., 2011).  Wang and Lim (2013) found diabetic mellitus to be a risk factor 
associated with death among necrotizing fasciitis patients (p.139). However, Wang and 
Lim (2013) showed that chronic renal disease was not statistically significant in risk 
factors associated with death and obesity was not statistically evaluated in this study 
(p.140). Oud and Watkins (2015), Lee et al. (2011), and Wang and Lim (2013) studies 
illustrate that further investigation of diabetes, obesity, and chronic renal disease as risk 
factors associated with necrotizing fasciitis patients and if the risk factors are mediated by 
gender and survival time.  
Age, Insurance, and Region of Residence Association with Survival of Necrotizing 
Fasciitis  
 Older age has been one of the factors that has emerged in research as a risk factor 
for necrotizing fasciitis (Krieg, Dizdar, Verde, & Knoefel, 2014; Oud & Watkins, 2015; 
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Ryseel et al., 2010; Vijayakumar et al., 2014). Insurance type and place of residency has 
not been well examined in survival analysis in necrotizing fasciitis patients. Krieg et al. 
(2014) retrospectively reviewed records from 1996 and 2011 at a single university 
hospital (p. 334). The researchers found 64 cases of necrotizing fasciitis infection (Krieg 
et al., 2014). The researcher’s results illustrated that age greater than 60 was a 
demographic characteristic that effected mortality among the patients with necrotizing 
fasciitis (Krieg et al., 2014). Krieg et al. (2014) did not analyze insurance type or place of 
residency in their study. Limitations in Krieg et al. study were retrospective study design 
and small sample size (p. 35). As previously mentioned, Oud and Watkins (2015) 
retrospectively reviewed Texas Inpatient Public Use Data Files from 2001 to 2010 (p. 2).  
The researchers found that age greater than 65 was a predictor of mortality among 
hospitalizations with necrotizing fasciitis (Oud & Watkins, 2015). Moreover, Oud and 
Watkins (2015) found that zip code of residence was not associated with increased risk of 
death after controlling for covariates (p. 4). Oud and Watkins (2015) did not look into 
insurance type for statistical analysis. However, the researchers did analyze income level, 
which was found to not be an association for mortality among patients with necrotizing 
fasciitis (Oud & Watkins, 2015). Khamnuan et al. (2015) retrospective review of three 
hospitals in Thailand found age greater than 60 and patients with no education had a 
greater risk for mortality using a univariable analysis (p.3). Khamnuan et al. (2015) did 
not analyze place of residency as a factor associated with mortality in their study. Krieg 
et al. (2014), Oud and Watkins (2015), and Khamnuan et al. (2015) studies illustrate that 
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further investigation in the United States of how age, education, and place of residency is 
warranted and if the factors are moderated by gender in a survival analysis.  
Summary and Conclusion 
Chapter 2 provided information over necrotizing fasciitis literature and research. 
Necrotizing fasciitis infections have high mortality (Golger et al., 2007; Oud & Watkins, 
2015). Survival analysis and statistical evaluation of medical charts in necrotizing 
fasciitis research has illustrated that predictors of mortality fluctuate marginally 
depending on each study (Bakleh et al., 2005; Golger et al., 2007; Lee et al., 2011; 
Yaghoubian et al., 2007). The predominant factors associated with mortality in 
necrotizing fasciitis patients while in the hospital were: moderate-to-severe neutrophilic 
infiltration with infected necrotizing fasciitis tissue, age, immune status, obesity, 
streptococcal toxic shock syndrome, history of cancer, intravenous drug abuse, elevated 
white blood cell count, being transferred outside the hospital, admissions temperature, 
low systolic blood pressure upon admissions, LRINEC score less than or equal to 6, 
chronic liver dysfunction, chronic renal failure, reduced serum albumin values, 
thrombocytopenia, immature leukocyte more than 10%, hypotension are associated with 
mortality in necrotizing fasciitis patients while in the hospital (Bakleh et al., 2005; Fann 
et al., 2011; Golger et al., 2007; Lee et al., 2011; Su et al., 2008; Yaghoubian et al., 
2007).  
The relationship of how gender is associated with mortality is still limited in 
research (Khamnuan et al., 2015; Light et al., 2010; Oud & Watkins, 2015; Wang & Lim, 
2013). Two researchers found females having a lower survival rate compared to men with 
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necrotizing fasciitis infection (Khamnuan et al., 2015; Wang & Lim, 2013). Additionally, 
two other research groups noticed conflicting data associated with gender and survival of 
necrotizing fasciitis patients (Lee et al., 2011; Oud & Watkins, 2015). Though, only one 
study was conducted in the United States. Statistically evaluating current patients who 
have been diagnosed with necrotizing fasciitis through a survival analysis specifically 
looking into gender will aid in the ability for hospitals, doctors, and practitioners to better 
care for these individuals. This study will provide the first in the United States to 
statistical measure the association of gender on survival time for necrotizing fasciitis 
patients. Furthermore, this study will determine if the gender is mediated from diabetes, 
obesity, and chronic renal disease in the survival analysis as well as if gender has an 
effect modification from age, education, and region of residence.   
In Chapter 3, I will give the details of the study, including the research design and 
the rationale. I will give details over the dependent and independent variables, and the 
rationale for the research questions. I will give details over sampling, the population, and 
how the data was collected. I will also give details over the software used for analysis, 
threats to validity of the study, and ethical issues that may arise.   
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Chapter 3: Research Method 
Introduction 
Necrotizing fasciitis is an uncommon but highly fatal infection. Mortality can be 
as high as 65% (Mukhopadhyay et al., 2011). Many factors associated with mortality in 
patients with necrotizing fasciitis has been well-defined (Bakleh et al., 2005; Fan et al., 
2011; Golger et al., 2007; Lee et al., 2011; Su et al., 2008; Yaghoubian et al., 2007). 
Though, research in gender-related mortality is still misunderstood. The purpose of this 
study was to examine the association that gender plays on survival time of patients who 
have been diagnosed with necrotizing fasciitis while still in the hospital. Additionally, 
this research examined factors that can be mediated and moderated by gender-related 
survival of necrotizing fasciitis infections. A number of reasons influenced this research, 
including the minimal studies looking into gender-related survival in necrotizing fasciitis 
patient and no current research at population-level conducted in the United States over 
this area. Furthermore, there are no studies that use gender to examine if there is 
modification in survival while in the hospital by sociodemographic risk factors or 
mediated by risk factors.  
In Chapter 3, I give the particulars of the study, including the rationale why the 
research design was chosen over other research designs. I present details over the 
dependent and independent variables, and the rationale for the research questions. I 
provide information over sampling, the population, and how the data was collected. I also 
give specifics over the software used for analysis, threats to validity of the study, and 
ethical issues that may arise. 
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Research Design and Rationale 
In this quantitative investigation, I used a cross-sectional design for the study. 
Cross-sectional study design was the most appropriate choice for this study because it 
allows for data to be analyzed at a single point in time to answer the research questions.  
In this study, gender and survival analysis were measured through the State Inpatient 
Database (SID). The outcomes for the research questions signify an outline of the 
frequency and association of components under examination over a 5-year period, 2008-
2012.  
Justification for Using the Design 
The rationalization for the design of this study is founded on previous studies 
done (Khamnuan et al., 2015; Light et al., 2010; Oud & Watkins, 2015; Wang & Lim, 
2013). These researchers used a type observational study to analyze several variables in 
necrotizing fasciitis patients as will my study. Oud and Watkins (2015) and Khamnuan et 
al (2015) both used a cohort study design to examine variables associated with mortality 
and necrotizing fasciitis patients. Cohort study design is advantageous when looking into 
several outcomes of interest in one study (Mann, 2003). A cohort study was not chosen 
for this research because there was not a need to follow the group of participants for any 
period of time to answer the research questions. Light et al. (2010) and Wang and Lim 
(2013) used retrospective chart reviews to describe clinical features and outcome 
measures of necrotizing fasciitis patients. Retrospective chart reviews are valuable in 
gathering study results (Vassar & Holzmann, 2013). However, there is lower 
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generalizability than cross-sectional studies since they are typically done in a limited 
number of clinics or hospital settings.  
Additionally, experimental study designs were not chosen for this research 
because there is not a need to manipulate the variables in the study. Nor was there a need 
for pre-testing or post-testing to examine the relationship between the variables. Quasi-
experimental designs were not chosen because the length of time to match many of the 
cases to proper controls, the cost of increasing years of data usage, and the complexity is 
not needed for this study’s research questions to be examined. The pre-experimental 
study designs were not chosen because they do not fit the research questions or study 
parameters. For the purposes of this research, a cross-sectional study is the most 
beneficial. Cross-sectional studies look at whole populations and/or subset of the 
population at a particular point in time (University of Michigan, 2010).The cross-
sectional design is specifically linked to the research questions that I seek to see if there is 
a relationship between. The main research question is: is there a difference in survival, by 
gender, for patients hospitalized for necrotizing fasciitis infections. Using the cross-
sectional design, I can focus on the linkage between the independent variable, gender, 
and the dependent variable, survival time. Additional analysis can be made of the 
mediating and moderating variables through the cross-sectional design.  
Operational Use of the Conceptual Framework  
Researchers are taking the life course theory in a new direction by looking at 
specific points in a person’s life. This is particularly useful in this cross-sectional study to 
understand the specific time period of survival for each individual case of necrotizing 
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fasciitis while still encompassing the many other factors that influence a person’s survival 
after the infection of the disease (Mayer, 2009). As applied in this study, the life course 
approach can focus on the outcomes in necrotizing fasciitis with the physical and social 
exposures (i.e. gender, sociodemographic factors, and risk factors) that play into the 
outcome measures of surviving necrotizing fasciitis (Hall, Yee, & Thomas, 2002). The 
life course approach indicates that there is an interplay of biological, social, and 
psychological factors that influence the life course of each individual (Hall, Yee, & 
Thomas, 2002). This applies to this study through the age of the participants acquiring 
necrotizing fasciitis infection and the time after acquiring necrotizing fasciitis infection 
possibly could influence the risk factors that are associated with necrotizing fasciitis 
infections along with survival of the infection (Hall, Yee, & Thomas, 2002; Light et al., 
2010).  
Moreover, the life course approach implies an insight of the effects of the 
environment while allowing the assumption that individuals change in a changing 
environment (Kuh et al., 2003). Furthermore, time is one of the key issues in the life 
course approach and denotes in the life course model that the individual at the time of a 
particular risk (necrotizing fasciitis infection) is assumed to affect the outcome (survival) 
(Kuh et al. 2003). The life course model also includes the understanding that health-
related outcomes (risk factors) are dependent on the time of the events and each 
individual’s characteristics (Kuh et al., 2003). One of the main reasons that the life course 
model is a fitting theoretical model is because the multifaceted nature of the model. The 
life course model correlates well with how outcomes of necrotizing fasciitis patients 
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interact with their environment, biological elements that are associated with 
demographic, risk factors of necrotizing fasciitis infection, and survival time after the 
initial infection (Kuh et al., 2003; Light et al., 2010). Lastly, the cross-sectional nature of 
this study collaborates time sensitive data collection which is fitting in this model. The 
life course model offers a perspective of the life course of the individuals in the study and 
a prediction of the age-graded, time-relevant data that is gathered to examine the gender 
differences along with risk factors that may be associated with survival time of 




The population of the study was made up of the patients from the SID which is a 
part of the family of databases and software tools developed for the Healthcare Cost and 
Utilization Project (HCUP) (Healthcare Cost and Utilization Project, 2015). SID includes 
inpatient discharge records from community hospitals in that 48 states (Healthcare Cost 
and Utilization Project, 2015). SID contains the universe of the inpatient discharge 
abstracts in all participating states (Healthcare Cost and Utilization Project, 2015). SID 
encompasses 97% of all U.S. community hospital discharges (Healthcare Cost and 
Utilization Project, 2015). The core set of information in the dataset from SID is clinical 
and nonclinical information on all patients, including principle and secondary diagnoses 
and procedures, admission and discharge status, patient demographic characteristics, 
expected payment source, total charges, and length of stay (Healthcare Cost and 
Utilization Project, 2015).  
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The participants were defined by those who had been diagnosed with necrotizing 
fasciitis between 2008 and 2012 and died in the hospital. Due to the rarity of the disease, 
and to efficiently capture all possible cases of necrotizing fasciitis, I combined five years 
of data starting from 2008 from the National Inpatient Sample (NIS) to the SID (Charnot-
Katsikas et al., 2009; Kobayaski et al. 2011; Zackarias et al., 2010). Additionally, 
participants were included who had one of the following comorbidity conditions and/or 
risk factors: diabetic, obesity, and chronic renal disease.  
Sampling and Sampling Procedure 
Through secondary data collection, the sample size was drawn. The sampling 
strategy that was used in this study is a nonprobability sampling procedure. It does not 
involve randomization. A primary feature of non-probability sampling is that samples are 
chosen by the personal judgment of the investigator, rather than random choice. While 
certain researchers might see non-probability sampling procedures as substandard to 
probability sampling procedures, there are solid theoretical and sensible rationale for the 
application of non-probability sampling (Canada Statistics, 2013). A chief goal of non-
probability sampling is to look at the intricacies of the sample being studied. In addition, 
non-probability sampling is beneficial for concealed and/or hard-to-reach subsets of the 
populations (Frankfort-Nachmias, & Nachmias, 2008).  
Necrotizing fasciitis has a very small incidence rate for annual occurrence. For the 
adult group of participants, the incident rate has been calculated to be around 0.4 per 
100,000 cases (Edlick, 2013, para.6). Due to the very small population for the study, 
purposive sampling would best fit the study parameters. This means that all patients 
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during the 5-year time period were purposively sought out and sampled with the 
recognition that this sample may not be a direct representation of national makeup. The 
aim of purposive sampling is to spotlight on specific distinctiveness of a population 
which best match the research question(s) (FAO Corporate Document Repository, 2011, 
para. 5). The chief advantage of purposive sampling is the comparative simplicity for the 
study to include participants. The primary disadvantage for this kind of sample is 
generalization to external people is difficult to do since the inclusion criteria that are used 
in the sampling techniques and is prone to research bias (FAO Corporate Document 
Repository, 2011). 
The inclusion criteria will include all participants in the study period that have 
been diagnosed with necrotizing fasciitis and died while in the hospital. The exclusion 
criteria will include missing data on any of the cases. A G*Power analysis was ran for the 
sample size. The large sample, z-test, logistic regression, a priori was chosen with one 
tail, power at 80 percent, and alpha at 0.05. The G*Power test illustrates there should be 
396 participants in the study for 80 percent power.  
Data Collection  
This study did not involve any recruitment of participants as it was conducted 
with secondary data collection methods. Though, it is important to explain how data was 
recruited into the study for further statistical analysis. I undertook the secondary data 
collection through the SID dataset, which is includes inpatient discharge records from 
community hospitals in that state (Healthcare Cost and Utilization Project, 2015). The 
SID files encompass all patients, regardless of payer, providing a unique view of 
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inpatient care in a defined market or state over time (Healthcare Cost and Utilization 
Project, 2015). Moreover, distinctions with respect to mediating and moderating variables 
was collected and was subject to thorough analysis to help establish further understanding 
of gender-related mortality in necrotizing fasciitis patients. The main clinical outcome 
that was measured is mortality. The mediating variables that were included diabetes, 
obesity, and chronic renal disease. The moderating variables in this study which were 
included are age, education, and region of residence.  
Since this is a cross-sectional study using secondary data from the SID, there was 
no need to provide informed consent, nor was there a need for participants to exit the 
study or any follow-up procedures needed. Any data that was collected that was missing 
variables was excluded from this study. Additionally, this study was subject to Walden 
University IRB approval.  
Use of Archival Data 
Secondary data collection is the re-investigation of data that have been collected 
by another source through raw or published data (Doolan & Froelicher, 2009; Smith et 
al., 2011). Secondary data collection and analysis have similar phases to primary data 
collection methods. The phases include: (1) describing the research subject and questions; 
(2) choosing the dataset to be used; (3) familiarizing yourself with the data that were 
selected; and (4) presenting your findings (Doolan & Froelicher, 2009; Smith et al., 
2011). There are several reasons to conduct a secondary data collection and analysis. 
First, the research is less obtrusive than other types of collection methods (Doolan & 
Froelicher, 2009; Smith et al., 2011). The time spent on collection is less and the cost of 
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secondary data analysis is minimal compared to many primary data collection methods 
(Doolan & Froelicher, 2009; Smith et al., 2011). The research can cover a wider 
demographic of people and increase the sample size used in the study (Doolan & 
Froelicher, 2009; Smith et al., 2011). Even though there are several advantages to 
collecting data through secondary sources there are still limitations of this type of data 
collection method. A major limitation in secondary data collection is that there is less 
control over the sampling population than primary data collection methods (Doolan & 
Froelicher, 2009; Smith et al., 2011). Additionally, secondary data can have limited 
access or be difficult to obtain, modification of the data may have already occurred, there 
may be poor documentation of the data, and confidentiality still needs to be considered 
for the usefulness in the research (Doolan & Froelicher, 2009; Smith et al., 2011).  
For the use of the SID, each research is required to take the online HCUP Data 
Use Agreement Training Course, and users of the SID must read and sign the Data Use 
Agreement for State Databases prior to the purchase of the data (Healthcare Cost and 
Utilization Project, 2015). A copy of the data use agreement is in the appendix of the 
study.  
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Data Analysis Plan 
 IBM Statistical Package for the Social Sciences (SPSS) Statistics 21 (SPSS 21) 
was used to run the analysis of the data. IBM SPSS 21 is a systematic tool that aids in 
understanding for data examination with precise results and allows one to assess all 
outcomes of interest (IBM, 2015). This statistical software is a suitable choice due to its 
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ability to conduct descriptive and inferential analysis over the dataset that was used in 
this study. SPSS 21 was loaded on the researcher’s personal computer and password 
protected.  
Research Question 1: “For the people who have been diagnosed with and died 
from necrotizing fasciitis, is there a significant difference in mean survival time between 
the genders while in the hospital?” The dependent variable is survival time and the 
independent variable is gender. Research Hypothesis 1: There will be a significant 
difference in mean survival time between genders among those who have been diagnosed 
with and died from necrotizing fasciitis while in the hospital. Kaplan-Meier method will 
be used to analyze this relationship. Kaplan-Meir probability is calculated through the 
number of subjects surviving living at the start minus the number of subjects who died 
divided by the number of patients living at the start (Goel, Khanna, & Kishore, 2010). 
Subjects that are censored, dropped out, and/or excluded are not counted in the 
denominator.  
Research Question 2: “Is any difference in mean survival time between genders 
while in the hospital modified by sociodemographic risk factors which is defined as age, 
insurance state, and region?” The null and alterative hypotheses associated with Research 
Question 2 are as follows:  
H2o1: The difference in mean survival time between genders while in the hospital will not 
be modified by age. 
H2a1: The different in mean survival time between genders while in the hospital will be 
modified by age. 
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H2o2: The difference in mean survival time between genders while in the hospital will not 
be modified by insurance state. 
H2a2: The different in mean survival time between genders while in the hospital  
will be modified by insurance state. 
H2o3: The difference in mean survival time between genders while in the hospital will not 
be modified by region. 
H2a3: The different in mean survival time between genders while in the hospital will be 
modified by region. 
To test these hypotheses, bivariate analysis was used. Moderating variables change the 
strength of an effect or relationship between two variables (i.e. survival time and gender). 
Thus cox proportional hazards was used to examine the effect of each moderating 
variables.  The exponential of the coefficients from the Cox model gives the rapid 
relative risk for a rise of one unit for each covariate in question.  
Research Question 3: “Is there any difference in mean survival time between 
genders while in the hospital mediated by pre-existing medical conditions, which is 
defined as diabetes, obesity, and chronic renal disease?” The null and alterative 
hypotheses associated with Research Question 3 are as follows:  
H3o1: The difference in mean survival time between genders while in the hospital will not 
be mediated by diabetes. 
H3a1: The difference in mean survival time between genders while in the hospital will be 
mediated by diabetes.  
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H3o2: The difference in mean survival time between genders while in the hospital will not 
be mediated by obesity. 
H3a2: The difference in mean survival time between genders while in the hospital will be 
mediated by obesity. 
H3o3: The difference in mean survival time between genders while in the hospital will not 
be mediated by chronic renal disease. 
H3a3: The difference in mean survival time between genders while in the hospital will be 
mediated by chronic renal disease.  
To test these hypotheses, bivariate analysis was used. Mediating variables specific how or 
why a particular effect or relationship may have occurred. For example, obesity may be 
associated with males to have a lower survival time for those diagnosed with and died 
from necrotizing fasciitis. Therefore, Cox proportional hazards was used to examine if 
there is an association through unadjusted estimates of the association between each 
mediating variable: diabetes, obesity, and chronic renal failure. Next, the research tested 
through Cox proportional hazards if there was an association between each mediating 
variable and the independent variable and each mediating variable and the dependent 
variable. If the independent and/or dependent variable is not associated with the 
mediating variable then the research can conclude that the variable is not mediated.  
Threats to Validity 
External validity refers to the generalizability of the study (Frankfort-Nachmias & 
Nachmias, 2008). People, places, and time can be threats to external validity (Frankfort-
Nachmias & Nachmias, 2008). This study is cross-sectional study design which is 
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contingent on the study years of 2008-2012. Thus, the generalizability of time can only 
be assumed in this time frame. Misclassification is the main external threat to validity and 
temporal relationships cannot be established. Additionally, since this study is cross-
sectional in nature, there cannot be a cause-and-effect relationship assumed for the 
population and study variables for other researchers (Frankfort-Nachmias & Nachmias, 
2008). Though, the use of a large population that covers 97% of the of all U.S. 
community hospital discharges aids in the external generalizability of people and place in 
the United States with necrotizing fasciitis during the study period.  
Internal validity is the extent the results of the study are true ((Frankfort-
Nachmias & Nachmias, 2008). Purposive sampling is a limitation in internal validity. 
However, and as mentioned previously, necrotizing fasciitis is a rare disease and 
purposive sampling is the best method to focus on specific characteristics of the 
population and have a robust population under study (Frankfort-Nachmias & Nachmias, 
2008).  
Ethical Procedures 
Ethical standards will be upheld in this study. Secondary data collection does not 
include informed consent. However, data usage is restricted to this particular research, 
online HCUP data use agreement training course was taken, and prevention of other 
researchers obtaining this data has been safeguarded. I have completed a human subject 
data handling agreement through the Walden University. All data have excluded personal 
identifiers and data will remain confidential to the researcher. The data will be stored on 




This research is a cross-sectional, quantitative research study with the use of 
secondary data from the HCUP and SID that will explore the relationship between 
gender-related mortality among patients who have been diagnosed with and died from 
necrotizing fasciitis. The data used was collected during the years of 2008 to 2012 with a 
total number of patients being roughly 396 to have 80 percent power and 0.05 alpha. 
Purposive sampling was used due to the rare nature of necrotizing fasciitis infections in 
the population. Analysis was through IBM Statistical Package for the Social 
Sciences (SPSS) Statistics 21 using Kaplan-Meir method and Cox proportional hazards to 
analyze the research questions and data. Chapter 4 will review the purpose of the study, 













Chapter 4: Results 
Introduction 
The purpose of this cross-sectional study is threefold. First, it was to analyze the 
association of gender on survival time for cases who had necrotizing fasciitis and died 
while in the hospital. The second part was to analyze the relationship between survival 
time, gender, and the modifying variables in the study, which include: age, insurance 
state, and region for patients who have been diagnosed with and died from necrotizing 
fasciitis. Third, was to analyze the relationship between survival time, gender, and the 
mediating variables for this study, which are: obesity, diabetes, and chronic renal failure. 
Descriptive statistics were used to illustrate basic information over the patients that where 
included in the study. In this chapter, I provide a better understanding of the association 
between survival time, gender, along with the modification of age, insurance state, and 
region, and the mediation of obesity, diabetes, and chronic renal failure using Kaplan-
Meier and Cox proportional hazards for inferential statistics. The following research 
questions and their connected hypothesis guided this study:  
1. For the people who have been diagnosed with and died from necrotizing 
fasciitis, is there a significant difference in mean survival time between the genders while 
in the hospital? 
Ho1: There will be no significant difference in mean survival time between genders 




HA1: There will be a significant difference in mean survival time between genders 
among those who have been diagnosed with and died from necrotizing fasciitis while in 
the hospital. 
2. For the people who have been diagnosed with and died from necrotizing 
fasciitis, is any difference in mean survival time between genders while in the hospital 
modified by sociodemographic risk factors of age, insurance state, and region?  
Ho1: The difference in mean survival time between genders among those who have been 
diagnosed with and died from necrotizing fasciitis while in the hospital 
is not modified by sociodemographic risk factors of age, insurance state, and region. 
HA2: The difference in mean survival time between genders among those who have been 
diagnosed with and died from necrotizing fasciitis while in the hospital 
 is modified by sociodemographic risk factors of age, insurance state, and region. 
3. For the people who have been diagnosed with and died from necrotizing 
fasciitis, is there any difference in mean survival time between genders while in the 
hospital mediated by pre-existing medical conditions of diabetes, obesity, and chronic 
renal disease?  
Ho1: The difference in mean survival time between genders among those who have been 
diagnosed with and died from necrotizing fasciitis while in the hospital is not mediated 
by pre-existing conditions of diabetes, obesity, and chronic renal disease. 
HA2: The difference in mean survival time between genders among those who have been 
diagnosed with and died from necrotizing fasciitis while in the hospital is mediated by 




Data for this study was obtained through the Healthcare Cost Utility Project 
(HCUP). The national-inpatient sample (NIS) is one of seven databases offered through 
HCUP. The NIS data was collected after IRB approval; IRB approval number is 07-22-
16-0196601. Once IRB approval was acquired, data from the NIS database was bought 
for the years of 2008-2012. After the payment of the NIS 2008-2012 dataset, HCUP 
attached ASC II files to convert to SPSS. Online HCUP data use agreement training 
course was taken prior to approval of IRB and the collection of data. I completed a 
human subject data handling agreement through the Walden University. All data have 
excluded personal identifiers and data will remain confidential to the researcher. The data 
will be stored on this researcher’s personal computer, password protected, and in an 
Excel spreadsheet.  
Data Analysis 
There were roughly 8 million cases in the NIS dataset for each year from 2008-
2012. The data was cleaned to include only participants who had a diagnosis one or 
diagnosis two of the 15 diagnosis offered through ICD-9 coding of necrotizing fasciitis 
and whom had died in the hospital. Diagnosis one of ICD-9 code for necrotizing fasciitis 
cases included 173 participants for 2008-2012 dataset. Diagnosis two of ICD-9 coded for 
necrotizing fasciitis included the remain of 420 cases for 2008-2012 dataset. The 
G*power analysis ran in chapter 3 illustrated that there was a total of 396 cases needed 
for 80% power. The final number of cases was 593 which is more than enough for the 
effect size and power needed in this study. After the inclusion criteria were met, missing 
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value analysis was conducted on the final participants. For the eight variables included in 
this study, there is less than 1% of missing data for seven of the eight variables. The only 
variable that had a higher percentage of missing data was region at 40%. The region 
variable was re-coded for the missing values, as 0, and all analysis of the missing data 




UNWEIGHTED PERCENTAGE OF MISSING VALUES BY 





LENGTH OF STAY 0.2% 
INSURANCE STATE 0.5% 
OBESITY 0.2% 
REGION 40.0% 






The target population for this study was all participants from the NIS dataset for 
the years of 2008-2012 that were diagnosed with necrotizing fasciitis and died while in 
the hospital. Descriptive statistics were ran on the target population. Table 3 shows the 
frequency counts for the selected variables. The population was split with almost half 
being men 50% (n=299) and half being woman 50% (n=294). The most prevalent race 
53 
 
was white at 56% (n=332), black at 13% (n=75), and Hispanic at 10% (n=57). Those 
aged 55 to 64 years old accounted for 27% (n=159) of the study population followed by 
age group 45 to 54 years old at 19% (n=115). Approximately 52% (n=307) used 
Medicare as their health insurance, while private insurance represented 20% (n=118) of 
the health care payee among the study population. The most predominant median 
household income of 38,999 or less with 34% of the cases (n=200), followed by medium 
income of 49,000 to 63,999 at 25% (n=148) and median household income of 39,000 to 
48,999 at 24% (n=141). The most common region cases were from was the South at 24% 
(n=145), then Midwest 13% (n=76), West 11% (n=68), and Northeast 11% (n=64). The 
percentage of diabetes was 13% (n=77), chronic renal failure 4% (n=25), and obesity 3% 
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There are several statistical assumptions for the use of Kaplan-Meier analysis. 
The first assumption is having two mutually exclusion states and exhaustive states (Goel 
et al., 2010). For this study, the event was death of necrotizing fasciitis cases. The second 
assumption for Kaplan-Meier analysis is the measurement of the “event” must be precise 
(Goel et al., 2010). This study event was the length of stay prior to death in the hospital. 
The third assumption is left-censoring should be minimized (Goel et al., 2010). This 
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study used the first and second out of the fifteen-diagnosis provided to minimize left-
censoring cases. The fourth assumption in Kaplan-Meier analysis is the independence of 
censoring of event (Goel et al., 2010). Since all cases died in this study, this assumption 
is void. The fifth assumption secular changes (Goel et al., 2010). The study collected data 
over a five-year period for cases that had been diagnosed with and died from necrotizing 
fasciitis. There has not been an improvement in treatment over the five-year study period 
to influence a secular change in this study. Lastly, the log-rank was ran to ensure 
censoring between groups were similar for the two groups being analyzed (male or 
female).  
Cox proportional hazards was used for research question two and three of this 
study. There are a couple of assumptions that need to be met using cox proportional 
hazards, which include: non-informative censoring and hazard function must be 
proportional over a specific period of time (Bender, Augustin, & Blettner, 2006). Non-
informative censoring was not an issue for this study due to the underlying nature of the 
variables in the study (Bender et al., 2006). Stated differently, this study focused on mean 
survival time for necrotizing fasciitis patients who had died in the hospital therefore there 
was not a follow-up period nor was there dependency on the necrotizing fasciitis patients 
having a follow-up since the research questions were only the cases that had died. Log-
log plots were ran for research question two (Figure 2) and research question three 
(Figure 3) to ensure that there was an absence of indication to oppose the proportionality 
assumption in the second assumption of cox proportional hazards. For the absence of 
proportionality, log-log plots should be approximately parallel (Bender et al., 2006). 
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Research Question 1 and Hypothesis 1 
Research Question 1: “For the people who have been diagnosed with and died 
from necrotizing fasciitis, is there a significant difference in mean survival time between 
the genders while in the hospital?”  
Ho1: There is no significant difference in mean survival time between the genders while 
in the hospital for the people who have been diagnosed with and died from necrotizing 
fasciitis. 
Ha1: There is a significant difference in mean survival time between the genders while in 
the hospital for the people who have been diagnosed with and died from necrotizing 
fasciitis. 
Kaplan-Meier Analysis  
 As shown in Table 4, I calculated the Kaplan-Meier analysis necrotizing fasciitis 
cases that had died to compare the length of stay between genders. The mean survival 
time for men was 11.7 days (95% CI of 9.4 to 14.0) and the mean survival time woman 
was 13.9 days (95% CI of 11.0 to 16.8). A log-rank test was performed to determine if 
there was statistical significant difference in mean survival time between the two genders. 
The mean survival time for the two genders was not statistically significantly different, 
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Figure 1: Survival Function between Genders for Necrotizing Fasciitis Cases 
 
 
Research Question 2 and Hypothesis 2 
Research Question 2: “For the people who have been diagnosed with and died 
from necrotizing fasciitis, is any difference in mean survival time between genders while 
in the hospital modified by sociodemographic risk factors which is defined as age, 
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insurance state, and region?” The null and alterative hypotheses associated with Research 
Question 2 are as follows:  
H2o1: The difference in mean survival time between genders while in the hospital will not 
be modified by age. 
H2a1: The different in mean survival time between genders while in the hospital will be 
modified by age. 
H2o2: The difference in mean survival time between genders while in the hospital will not 
be modified by insurance state. 
H2a2: The different in mean survival time between genders while in the hospital  
will be modified by insurance state. 
H2o3: The difference in mean survival time between genders while in the hospital will not 
be modified by region. 
H2a3: The different in mean survival time between genders while in the hospital will be 
modified by region. 
For research question 2 and shown in Table 5, I used bivariate analysis to assess 
three covariates: age, insurance state, and region, for the 597 cases of necrotizing fasciitis 
who died to see if there was a difference of survival time through the genders modified 
by the covariates. The covariate age was separated into seven ranges, which include: 
range 1) 24 or younger, range 2) 25 to 34 years, range 3) 35 to 44 years, range 4) 45 to 54 
years, range 5) 65 to 74 years, range 6) 75 to 84 years, and range 7) 85 and older. Since 
age group 55 years to 64 years was the most common, that range was used for the 
baseline comparison for all the remaining groups. Insurance state was separated into five 
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categories: 1) Medicaid, 2) Private insurance, 3) Self-pay, 4) No charge, and 5) Other. 
Medicare was the most common insurance for the cases and was used as a baseline for 
comparison in the analysis. The covariate region was separated into three regions: 1) 
Northeast, 2) Midwest, and 3) West. The South region was the most common region for 




Bivariate analysis using cox proportional hazard analysis examining covariates 
 that are associated with time to death among men and women diagnosed with 
 necrotizing fasciitis, 2008-2012 
Covariates Parameter 
Estimate 
SE  95% CI  
Age 
 
    
      24 years 
and younger 
-0.09 0.63  0.27-3.11 
      25 to 34 
years 
-0.71 0.38  0.23-1.03 
      35 to 44 
years  
-0.13 0.31  0.47-1.62 
      45 to 54 
years 
-0.72 0.24  0.31-0.77 
      65 to 74 
years 
-0.62 0.23  0.35-0.83 
      75 to 84 
years 
-0.46 0.22  0.41-0.98 
      85 and 
older 
 
-0.29 0.23  0.48-1.17 
Region 
 
    
     Northeast -0.30 0.19  0.52-1.07 
     Midwest -0.16 0.17  0.61-1.20 
     West 
 
-0.27 0.16  0.56-1.03 
Insurance 
 
    
     Medicaid -0.50 0.29  0.34-1.08 
     Private 
insurance 
-0.59 0.32  0.30-1.03 
     Self-pay -0.18 0.30  0.46-1.50 
60 
 
     No charge -0.25 0.32  0.42-1.47 
Note. CI=95% Confidence intervals 
 
The results indicate the significant values and hazard ratios (Exp (B)) of the 
covariates that included all the predictor variables with a significant p-value from the 
univariate analysis. A hazard ratio that is <1.0 means that the variable of interest is less 
likely to have a shorter time to event compared with the reference group and a hazard 
ratio >1.0 is more likely to have poorer survival with the reference group. Statistically 
significant differences for survival were observed in age (p=0.04). There was not a 
statistical significance in region or insurance type.   
The hazard ratio for age 45 to 54 years was 0.49, 95% CI [0.31-0.77] indicating 
that there was a 46% increase in mean survival time compared to the reference group (55 
to 64 years). The hazard ratio for age 65 to 74 years was 0.54, 95% CI [0.35-0.83] 
indicating that there was a 48% increase in mean survival time compared to the reference 
group while the hazard ratio for those 75 to 84 years was 0.63, 95% CI [0.41-0.98] 
indicating that there was a 57% increase in mean survival time compared to the reference 
group. 
Next, cox regression was ran by splitting the groups to analyze the genders for 
mean survival difference for necrotizing fasciitis cases that could be modified by age, 
region, and insurance type (Table 6). The results indicate that there is not statistical 
significance with female cases of necrotizing fasciitis who died modified by age, region, 
or insurance state. The results also indicate that male cases of necrotizing fasciitis who 
died where not modified by region or insurance state. The analysis does illustrate that age 
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is statistically significant for male necrotizing fasciitis cases and therefore modified the 
mean survival time for male necrotizing fasciitis case who died while in the hospital.  The 
hazard ratio for age in male cases was 1.17, 95% CI 1.03-1.32, which indicates that mean 




Cox proportional hazards, to examine whether differences in survival time between 
males and females diagnosed with necrotizing fasciitis, is modified by region, age, and 
insurance, 2008-2012 
 Covariate B SE p-value Exp(B) 95%CI  
Male       
 Region 0.04 0.08 0.62 1.04 0.89-1.21 
 Age  0.16 0.06 0.01 1.17 1.03-1.32 
 Insurance 0.08 0.06 0.17 1.08 0.97-1.21 
 
Female 
      
 Region 0.05 0.08 0.58 1.05 0.89-1.23 
 Age  0.08 0.06 0.18 1.08 0.96-1.21 
 Insurance 0.13 0.07 0.07 1.14 0.99-1.31 

























Figure 2. Log-Log plot of covariates: age, region, and insurance for male and female necrotizing fasciitis cases.  
 
Research Question 3 and Hypothesis 3 
Research Question 3: “Is there any difference in mean survival time between 
genders while in the hospital mediated by pre-existing medical conditions, which is 
defined as diabetes, obesity, and chronic renal disease?” The null and alterative 
hypotheses associated with Research Question 3 are as follows:  
H3o1: The difference in mean survival time between genders while in the hospital will not 
be mediated by diabetes. 
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H3a1: The difference in mean survival time between genders while in the hospital will be 
mediated by diabetes.  
H3o2: The difference in mean survival time between genders while in the hospital will not 
be mediated by obesity. 
H3a2: The difference in mean survival time between genders while in the hospital will be 
mediated by obesity. 
H3o3: The difference in mean survival time between genders while in the hospital will not 
be mediated by chronic renal disease. 
H3a3: The difference in mean survival time between genders while in the hospital will be 
mediated by chronic renal disease.  
For research question 3 and shown in Table 6, cox proportional hazard was used 
to assess mediation.  The three covariates examined to assess mediation included 
diabetes, obesity, and chronic renal disease, I first examined the bivariate association 
between time to death and having been diagnosed with diabetes, obesity or chronic renal 
failure among the 597 cases of necrotizing fasciitis who died between 2008 and 2012 
(Table 6).  The data provided evidence that those who had a previous diabetes diagnosis 
had statistically significant decreased survival times compared to those not diagnosed 







Cox Proportional Hazard of Covariates: Diabetes, Obesity, 
 and Chronic Renal Failure, for Necrotizing Fasciitis Cases,  
2008-2012 
Covariate Beta SE 95% CI  
Diabetes  
 
-0.46 0.13 0.49-0.81 
Obesity  
 
-0.43 0.25 0.40-1.06 
Chronic 
Renal Failure 
-0.28 0.21 0.50-1.14 
Note. 95% CI=95% confidence interval 
 
 The next analysis, Table 7, examined if the proportion of males and females 
diagnosed with diabetes, obesity and chronic renal failure differed.  There was a 
statistical significant difference in in the hazard ratio of male and female necrotizing 
fasciitis cases diagnosed with diabetes. Male necrotizing fasciitis cases had a hazard ratio 
of 0.69, 95% CI 0.49-0.97, which indicates that there is an increased rate of death among 
males who are diagnosed with diabetes compared to those not diagnosed with diabetes.  
We found similar results among females diagnosed with diabetes who experience an 
increased time to death compared to those not diagnosed with diabetes, hazard ratio of 
0.55, 95% CI 0.38-0.89, which indicates a 51% decrease in mean survival time for female 




COX PROPORTIONAL HAZARDS, EXAMINING DIFFERENCE IN SURVIVAL 
TIMES BY PREVIOUS DIAGNOSIS WITH DIABETES, OBESITY AND CHRONIC 
RENAL FAILURE, BETWEEN MALE AND 
FEMALE NECROTIZING FASCIITIS CASES, 2008-2012 
 Covariate B SE  95% CI  
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-0.21 0.28  0.47-1.40 












-0.48 0.33  0.33-1.18 
Note. CI=confidence interval; Coded diabetes diagnosis=1, no previous diabetes diagnosis=0; previous 
obesity diagnosis=1, no previous obesity diagnosis=0; previous chronic renal failure=1, no previous renal 
failure=0; *P<0.05 statistically significant. 
 
 
Lastly, I ran cox regression to analyze the association between survival time of 
necrotizing fasciitis cases and gender controlling for diabetes. Table 8 illustrates that 
diabetic male and female cases of necrotizing fasciitis cases is statistically significant 
for mean survival time. Male cases had a p-value of 0.01 while female cases had a p-









Cox Proportional Hazard for Survival time for Genders in  
Necrotizing Fasciitis Cases Controlling for Diabetes,2008-2012  
Indicator of 
Sex 


































Figure 3. Log-Log plot of covariates: diabetes, obesity, and chronic renal failure for male and female necrotizing 






The results of this study indicated that there is not a statistical difference in mean 
survival time between genders for those who have been diagnosed with and died from 
necrotizing fasciitis. Therefore, the null hypotheses of no significant difference in 
survival time between the genders while in the hospital for the people who have been 
diagnosed with and died from necrotizing fasciitis was not rejected. The researcher also 
determined that there was not an association mediated for mean survival time between 
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genders from obesity and chronic renal failure. The null hypothesis difference in mean 
survival time between genders while in the hospital will not be mediated by obesity or 
chronic renal failure is not rejected. Additionally, the null hypotheses of difference in 
mean survival time between genders while in the hospital will not be modified by region 
or insurance state was not rejected. This researcher did determine that there was an 
association modified for mean survival time between genders for age for the male cases 
of necrotizing fasciitis which illustrates that 54 years and younger of male cases had a 
better chance of mean survival compared to male necrotizing fasciitis cases with an older 
age. Furthermore, this researcher found that there was an association mediated from 
diabetes for mean survival time for both genders for those who have been diagnosed with 
and died from necrotizing fasciitis which illustrates that both genders with diabetes had a 
shorter length of mean survival time compared to cases without diabetes. 
Chapter 4 illustrated the study results to answer the overarching research 
questions. Chapter 5 will discuss an overview of the results, interpretation of the findings 
of this study, limitation in this study, give recommendations for further research, and 










Chapter 5: Discussion, Conclusions, and Recommendations 
The purpose of this cross-sectional, quantitative study was to examine survival 
time between genders for people who had been diagnosed with and died from necrotizing 
fasciitis during their time in the hospital. In this chapter, I will give an introduction, 
interpretation of the findings, limitations of the study, recommendations for future 
studies, illustrate the positive social change in the study, and implications.   
Mortality for people who have been diagnosed with necrotizing fasciitis ranges 
15% to 40% (Shimizu & Tokuda, 2010). In spite of the copious amount of research in 
diagnostic and treatment of necrotizing fasciitis, there is limited knowledge and research 
of survival analysis for short and long-term outcomes of necrotizing fasciitis patients who 
have been diagnosed with necrotizing fasciitis, particularly in the United States. This 
study sought to narrow the gap in a small way. This study used secondary data from the 
NIS for the years of 2008-2012 to answer the three main research questions, which were: 
1) For the people who have been diagnosed with and died from necrotizing fasciitis, is 
there a significant difference in mean survival time between the genders while in the 
hospital? 2) For the people who have been diagnosed with and died from necrotizing 
fasciitis, is any difference in survival time between genders while in the hospital modified 
by sociodemographic risk factors which is defined as age, insurance state, and region? 3) 
Is there any difference in mean survival time between genders while in the hospital 
mediated by pre-existing medical conditions, which is defined as diabetes, obesity, and 
chronic renal disease?   
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A sequence of analysis was conducted through bivariate and univariate statistical 
techniques. Kaplan-Meier was used to analyze the first research question while cox 
proportional hazards was used to analyze the second and third research questions. The 
results of the study were mixed. There was not a statistical significance in the mean 
survival time between genders for those diagnosed with and died from necrotizing 
fasciitis. However, there was a statistical significance for male necrotizing fasciitis 
patients that was modified by age for mean survival time. Additionally, there was a 
statistical significance that was mediated from diabetic status in both male and female 
necrotizing fasciitis patient’s mean survival time.  
Interpretation of Findings 
Survival Analysis, Gender, and Necrotizing Fasciitis 
Necrotizing fasciitis research has not focused noticeably on mean survival times 
and factors that influence mean survival times in short and long-term outcomes for 
patients in the United States (Light et al., 2010, Oud & Watkins, 2015). The few studies 
in the literature that have examined gender differences for mean survival time in 
necrotizing fasciitis patients chiefly found that women had a lower chance of survival 
than men (Khamnuan et al. 2015; Oud & Watkins, 2015; Wang & Lim, 2013). However, 
in this study, there was not a statistical significance for mean survival time between 
genders for necrotizing fasciitis patients; with the mean survival time for men at 11.7 
days and the mean survival time for woman at 13.9 days. The results of this study may 
have been different than previous literature due to the sample size being relatively small 
while the overall incidence of necrotizing fasciitis also remains small. Though, this study 
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does suggest that there is an equal probability of mortality for woman and men than what 
was previous suggested through the literature.  
Survival Analysis, Age, Insurance, Region, and Necrotizing Fasciitis 
The association of age, insurance type, and region was examined in this study. 
Consistent with Krieg et al. (2014), Khamnuan et al. (2014), and Oud and Watkins (2015) 
this study found a statistical significance in age and mortality in necrotizing fasciitis 
patients. Oud and Watkins (2015) found that age great than 65 was associated with 
mortality among both genders in necrotizing fasciitis patients. Most studies have not 
examined the association of mean survival time between genders and necrotizing fasciitis 
patients. This study found that male, 45 years and older, necrotizing fasciitis patients had 
a lower chance of mean survival compared to younger, 44 and younger, male necrotizing 
fasciitis patients while there was not a statistical difference in female necrotizing fasciitis 
cases. This was different than the studies presented in the research due to examining age 
as a modifying factor for mortality outcomes between genders in necrotizing fasciitis 
patients.  
There were not many studies that looked at association between insurance and 
region. Similar to Oud and Watkins (2015), this study found no association between 
region and mortality among necrotizing fasciitis patients. Many studies had not examined 
this region in mortality and outcomes for necrotizing fasciitis patients. Additionally, none 
of the studies presented in the research examined insurance type and mortality outcomes 
for necrotizing fasciitis patients. Even though, there was not a statistical difference in the 
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findings in this study, it does open a door for more understanding in necrotizing fasciitis 
and survival analysis for this type of research.   
Survival Analysis, Diabetes, Obesity, Chronic Renal Disease, and Necrotizing 
Fasciitis 
Survival analysis was ran on diabetes, obesity, and chronic renal failure for 
mortality in necrotizing fasciitis patients. There were mixed results in the literature over 
diabetic status increasing mortality among necrotizing fasciitis patients. Though, Oud and 
Watkins (2015) did find a high correlation to diabetic status and increased mortality in 
necrotizing fasciitis patients. This was correspondingly to the results shown in this study 
which illustrated that being diabetic had a higher mortality compared to those who are not 
diabetic for mortality in necrotizing fasciitis patients in both genders (Khamnuan et al, 
2015; Oud & Watkins, 2015). These results did go against Lee et al. (2011) and Wang 
and Lim (2013) study that found no statistical in diabetic status for morality outcomes in 
necrotizing fasciitis patients.  
Going against Oud and Watkins (2015), this study did not find a statistical 
significance in mortality for necrotizing fasciitis patients mediated by obesity or chronic 
renal failure. The results of this study may have not shown statistical insignificant due to 
the smaller sample size compared to Oud and Watkins study. This study was aligned with 
the findings from Wang & Lim (2013) who found no statistical significance obesity or 
chronic renal failure for necrotizing fasciitis mortality outcomes.  
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Limitations of the Study 
There are a few noted limitations in this study. The major limitation is the use of 
secondary data, which falls under the umbrella of misclassification. Misclassification can 
occur in secondary data when there are errors in data entry or diagnosis (Frankfort-
Nachmias & Nachmias, 2008). Due to the threat of external validity by misclassification 
of secondary data than this study recognizes that temporal relationships cannot be 
recognized (Frankfort-Nachmias & Nachmias, 2008). Additionally, since this study is 
cross-sectional in nature, there cannot be a cause-and-effect relationship assumed for the 
population and study variables for other researchers (Frankfort-Nachmias & Nachmias, 
2008). Though, the use of a large population that covers 97% of the of all U.S. 
community hospital discharges aids in the external generalizability of people and place in 
the United States with necrotizing fasciitis during the study period. Lastly, internal 
validity is the extent the results of the study are true ((Frankfort-Nachmias & Nachmias, 
2008). Purposive sampling is a limitation in internal validity. However, and as mentioned 
previously, necrotizing fasciitis is a rare disease and purposive sampling is the best 
method to focus on specific characteristics of the population and have a robust population 
under study (Frankfort-Nachmias & Nachmias, 2008).  
Recommendations for Future Research 
Future research should focus on longer term outcomes of mean survival analysis 
of necrotizing fasciitis patients between genders. This research solely examined patients 
who had died while in the hospital. It would be beneficial to examine mean survival 
difference between genders of those who survive the initial stay in the hospital and see if 
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there is a statistical difference in mean survival time between the genders. Other studies 
could extent the years examined, since this study included a five year period, it would be 
beneficial to examine mean survival time in a ten year period for those who had been 
diagnosed with and died from necrotizing fasciitis and see if there is a difference between 
gender for mean survival time.   
Another area that should be examined is the length of mean survival time for both 
genders in necrotizing fasciitis patients after leaving the hospital for those who have 
diabetes and those who do not have diabetes. Moreover, examining other demographic 
variables, like income, education, and inter-hospital transfer, would be helpful for mean 
survival time analysis for necrotizing fasciitis patients between genders and for both 
genders.  Lastly, examining the mean survival time for both genders for other pre-
existing conditions would be beneficial for necrotizing fasciitis research in the United 
States.  
Implications 
Positive Social Change 
Increasing the knowledge of necrotizing fasciitis survival is of utmost importance 
to not only educate health practitioners and patients but also implement better practices of 
care. This research added to social change in the several ways. First, at a community 
level, this study gave more overall knowledge of necrotizing fasciitis survival factors in 
the United Sates and give health practitioners and patients of necrotizing fasciitis a more 
comprehensive awareness of the infection. This research also added to the body of 
literature in necrotizing fasciitis research. This study is unique in the manner that it is one 
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of the initial endeavors in the United States to statistically measure necrotizing fasciitis 
regarding gender, sociodemographic factors, and risk factors that can be associated with 
the mean survival time. This study was also unique in the manner that it is the only study 
that looked specifically at how sociodemographic factors and risk factors were associated 
to mortality outcome between the genders of necrotizing fasciitis patients. The results of 
the study aided to a better understanding of mortality outcomes between genders for 
necrotizing fasciitis patients. The study results also illustrated that both genders have an 
equal probability of mean survival time which went against most research findings. The 
study results found that diabetic status and older age for men were contributing factors to 
higher mortality for necrotizing fasciitis patients in the United States which gives public 
health, health practitioners, researchers, and patients more knowledge of the mortality 
outcomes.  
Recommendations for Practice 
Mortality of people diagnosed with necrotizing fasciitis ranges from 15% to 35% 
which is high for any bacterial infection. This research aimed to increase the knowledge 
of mortality outcomes to aid in the information and potentially help in different areas that 
treatment could focus on for patients of the infection. Older age and diabetic status are 
two key factors that contribute to higher mortality of people diagnosed with necrotizing 
fasciitis. Public health practitioners and providers can help reduce factors that contribute 
to mortality in necrotizing fasciitis by a better understanding of what is causing it. This 
study narrowed that gap in a small way and illustrated that diabetic status is a major issue 
79 
 
in mean survival time for necrotizing fasciitis patients which should be taken into account 
while treating them in short-term and long-term settings.  
Conclusion 
Necrotizing fasciitis is an uncommon bacterial infection. Yet, mortality rates still 
remain high ranging from 32% to 65% and the cost for the United States runs from 
$50,000 to $100,000 per patients (Mukhopadhyay, et al., 2011; Widjaja, et al., 2005). 
Since necrotizing fasciitis is rare, diagnoses can be problematic because it can often be 
overlooked but extensive research has revealed best practices for diagnostics of 
necrotizing fasciitis to be surgical exploration and tissue biopsy (Davoudian & Flint, 
2012). Research has also focused much attention on treatment of necrotizing fasciitis 
which illustrates that surgical debridement and antibiotic treatment to be the best course 
of action (Anaya & Dellinger, 2007; Meyers, 2012; Shimizu & Tokuda, 2010). 
Management and survival analysis has limited research in necrotizing fasciitis 
outcomes. This leaves a gap in knowledge for health practitioners, public health, patients, 
and families of those diagnosed with necrotizing fasciitis. Along with a few other 
researchers, this research starts to close the hole in the unknown for survival analysis and 
outcomes for necrotizing fasciitis patients. The results illustrate that there is an equal 
chance of survival for both genders that had not been previously studied. Additionally, 
the results of this study, illustrated that older men have a lower chance of mean survival 
from necrotizing fasciitis than younger men. However, women’s age was not statistically 
significant in mean survival outcomes. Lastly the results of this study, show that both 
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genders have a higher mortality when the patient is diabetic compared to those that are 
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